var title_f23_48_24320="Posterior scleritis in Cogans";
var content_f23_48_24320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F77595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F77595&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe posterior scleritis in Cogan's syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computerized tomography of the orbits shows thickening and enhancement of both posterior sclera in this patient with Cogan's syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: MacCallum RM, St. Clair EW, Haynes BF. Cogan's syndrome. In: Inflammatory Diseases of Blood Vessels. Hoffman GS, Weyand CM (Eds). Marcel Dekker, Inc, New York City 2002. Copyright &copy; 2002 Marcel Dekker, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24320=[""].join("\n");
var outline_f23_48_24320=null;
var title_f23_48_24321="Lymph nodes female PI";
var content_f23_48_24321=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77184&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Lymph node groups in women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 584px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The green dots indicate the location of lymph nodes, which are found throughout the body.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24321=[""].join("\n");
var outline_f23_48_24321=null;
var title_f23_48_24322="Blood in fetal bowel";
var content_f23_48_24322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Echogenic fetal bowel at 15 weeks' gestational age in 33-year-old woman with vaginal bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sonogram revealed subchorionic hemorrhage (not shown). Sagittal scan through fetal abdomen reveals hyperechoic loops of bowel (arrow) as echogenic as adjacent bone. Cytomegalovirus titers and karyotype were normal, and findings of prenatal screening for cystic fibrosis were negative. Normal bowel echotexture was seen on follow-up 2 weeks later (not shown).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Trop I, Levine D. Hemorrage During Pregnancy: Sonography and MR Imaging. AJR Am J Roentgenol 2001; 176:607.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24322=[""].join("\n");
var outline_f23_48_24322=null;
var title_f23_48_24323="HGA annual incidence";
var content_f23_48_24323=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F72124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F72124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 558px\">",
"   <div class=\"ttl\">",
"    Average reported annual incidence* of human granulocytotropic anaplasmosis, by State-United States, 2001-2002&bull;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 538px; height: 386px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Per 1,000,000 persons per year.",
"     <br>",
"      &bull; Nonreporting states do not have a value and appear white.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:Demma LJ, Holman RC, McQuiston JH, et al. Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg 2005;73:400.",
"     <br>",
"      Champman, AS, Bakken, JS, Folk, SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever, Ehrlichioses, and Anaplasmosis -- United States: A practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24323=[""].join("\n");
var outline_f23_48_24323=null;
var title_f23_48_24324="Laryngoscope lifting";
var content_f23_48_24324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F62054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F62054&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laryngoscope lifting",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photograph shows the proper direction of forces applied for direct laryngoscopy. Note the assistant providing cricoid pressure (optional maneuver) and the proper shape of the endotracheal tube: straight to the cuff and with no greater than 35 degrees of angulation at the top of the cuff.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Orebaugh SL. Direct laryngoscopy. In: Atlas of Airway Management: Techniques and Tools, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24324=[""].join("\n");
var outline_f23_48_24324=null;
var title_f23_48_24325="Bilirubinate crystals";
var content_f23_48_24325=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80050&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Gallbladder bile microscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Amorphous brown bilirubinate crystals on microscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Salam F Zakko, MD, FACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24325=[""].join("\n");
var outline_f23_48_24325=null;
var title_f23_48_24326="Primary humoral immune deficiencies: An overview";
var content_f23_48_24326=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Primary humoral immune deficiencies: An overview",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24326/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24326/contributors\">",
"     Francisco A Bonilla, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24326/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24326/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24326/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24326/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/48/24326/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term primary immunodeficiency disease denotes disorders resulting from the mostly inherited defects of the immune system. Multiple isolated defects and combined disorders have been described, including humoral immune deficiencies, the severe combined immunodeficiencies, and disorders resulting from phagocytic and complement defects.",
"   </p>",
"   <p>",
"    The symptoms, signs, and molecular pathophysiology of the major humoral immune deficiencies will be reviewed here, as well as pertinent aspects of the laboratory evaluation and differential diagnosis. An overview of the laboratory abnormalities observed in the different primary humoral immune deficiencies is presented in the table (",
"    <a class=\"graphic graphic_table graphicRef70391 \" href=\"UTD.htm?13/33/13852\">",
"     table 1",
"    </a>",
"    ). General considerations and descriptions of methods used in the evaluation of immune system function are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRESENTATION OF HUMORAL IMMUNE DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Humoral immune deficiency refers to diseases resulting from impaired antibody production, because of either a molecular defect intrinsic to B cells or a failure of interactions between B and T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/1\">",
"     1",
"    </a>",
"    ]. Cellular immunity is largely intact, in contrast to diseases classified as combined immunodeficiencies, despite underlying T cell defects in some of these diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibody deficiency characteristically leads to recurrent, often severe, upper and lower respiratory tract infections with encapsulated bacteria (eg, Streptococcus pneumoniae, Haemophilus influenzae) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/2\">",
"     2",
"    </a>",
"    ]. Children commonly present with recurrent otitis media, sinusitis, and pneumonia. The same is true of adults, although otitis media is less common. Viral infections of the respiratory tract also occur with greater frequency and severity in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/3\">",
"     3",
"    </a>",
"    ]. Additional infectious diseases may be associated with particular syndromes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H4#H4\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Common associated findings in children include poor growth and failure to thrive, recurrent fevers, and poor school attendance and performance [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/4\">",
"     4",
"    </a>",
"    ]. Chronic diarrhea is seen in both children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/5\">",
"     5",
"    </a>",
"    ]. Autoimmune disease is occasionally the presenting feature in adults. Primary humoral immune deficiency should also be considered in patients with nodular lymphoid hyperplasia in the gut or unexplained hepatosplenomegaly.",
"   </p>",
"   <p>",
"    Patients with suspected antibody deficiency should have measurement of total serum IgG (",
"    <a class=\"graphic graphic_figure graphicRef73913 \" href=\"UTD.htm?31/25/32157\">",
"     figure 1",
"    </a>",
"    ), IgA, and IgM. The importance of IgD, IgE, and IgG subclass levels is controversial (see",
"    <a class=\"local\" href=\"#H11\">",
"     'Other antibody defects'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Specific antibody titers to protein (eg, tetanus, diphtheria) and polysaccharide (eg, pneumococcal polysaccharides, H. influenzae type B capsular polysaccharide) antigens should also be measured. If specific antibody levels are low, booster immunization should be administered and titers measured again four weeks later. Isohemagglutinins may be measured in infants who have not completed a primary series of immunizations, since such antibodies are usually detectable by six months of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24328?source=see_link\">",
"     \"Assessing the immunologic response to vaccination\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21446846\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for primary humoral immunodeficiencies includes milder forms of combined immunodeficiency (CID), protein losing states, and acquired humoral immune deficiency secondary to drug therapy or other causes. T cell defects in CID and decreased serum concentration of albumin in protein-losing gastroenteropathy differentiated these disorders from primary humoral immune deficiencies. Secondary causes of impaired antibody production should be considered in patients on immunosuppressive medications and in those with conditions that alter immune system function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link\">",
"     \"Combined immunodeficiencies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=see_link&amp;anchor=H2#H2\">",
"     \"Protein-losing gastroenteropathy\", section on 'Pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link\">",
"     \"Secondary immune deficiency induced by drugs and biologics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=see_link\">",
"     \"Secondary immune deficiency due to miscellaneous causes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     X-LINKED AGAMMAGLOBULINEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;X-linked agammaglobulinemia (XLA or Bruton's agammaglobulinemia) is due to a defect in Bruton's tyrosine kinase (Btk) that is expressed in B cells at all stages of development. Affected males with XLA generally experience recurrent bacterial infections of the respiratory tract (including otitis media, pneumonia, and sinusitis) initially occurring between 6 and 18 months of age. Enteroviruses, such as Coxsackievirus and ECHOvirus, are also problematic, as humoral immunity is the primary defense against these viruses. Among patients with profound hypogammaglobulinemia, findings highly suggestive of XLA are normal T cell numbers and absent or low B cell numbers. Most patients with classical XLA have &lt;1 percent CD19 or CD20 positive lymphocytes. The treatment of choice is replacement therapy with immune globulin. XLA is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=see_link\">",
"     \"Agammaglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     AUTOSOMAL RECESSIVE AGAMMAGLOBULINEMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical and laboratory features of autosomal recessive agammaglobulinemias (ARAs) are essentially identical to those of XLA described above. ARA is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=see_link\">",
"     \"Agammaglobulinemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     HYPERIMMUNOGLOBULIN M SYNDROMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyper-IgM syndrome (HIGM), also called \"immune deficiency with normal or elevated IgM\", is a somewhat obsolete term denoting deficiency of IgG, IgA, and IgE, with normal or elevated serum concentrations of IgM. Several gene defects have since been identified within this group of disorders, and it is preferable to refer to the specific defect to avoid confusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"     \"Hyperimmunoglobulin M syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Three disorders have been reclassified as combined immunodeficiencies because of associated abnormalities of cellular immunity:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common defect is X-linked hyper IgM syndrome due to deficiency of CD40 ligand (CD40L, also called CD154, or TNFSF5 for tumor necrosis factor superfamily member 5). An autosomal recessive form due to deficiency of CD40 (TNFRSF5 or tumor necrosis family receptor superfamily member 5) is also recognized. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"       \"Hyperimmunoglobulin M syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Another disorder, termed NEMO deficiency, is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=see_link&amp;anchor=H18#H18\">",
"       \"Combined immunodeficiencies\", section on 'Defects of NF-kappa-B regulation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two additional rare forms of hyper-IgM syndrome, with autosomal recessive inheritance and normal T cell function, are caused by defects in enzymes required for the process of immunoglobulin class-switching. Specifically, mutations in nucleic acid modifying enzymes called activation-induced cytidine deaminase (AICDA or AID, MIM 605258) and uracil nucleoside glycosylase (UNG, MIM 608106) have been demonstrated. B cells cannot change isotype production from IgM to IgG, IgA, or IgE during antigen-dependent development and thus only produce appreciable quantities of IgM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"     \"Hyperimmunoglobulin M syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"     \"The humoral immune response\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31098?source=see_link&amp;anchor=H1230945#H1230945\">",
"     \"Normal B and T lymphocyte development\", section on 'Maturation of activated B cells'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No specific defects have been identified in an additional group of patients with HIGM with residual IgG production (HIGM type IV, MIM 608184). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"     \"Hyperimmunoglobulin M syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AICDA and UNG deficiencies generally present with the recurrent and severe sinopulmonary infections with encapsulated bacteria that are characteristic of antibody deficiencies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Gastrointestinal infections (including Giardiasis), bacterial meningitis, viral encephalitis, and severe hepatitis B infections have also been observed.",
"   </p>",
"   <p>",
"    Lymphoid hyperplasia is seen in about two-thirds of patients. This may involve peripheral nodes, as well as mesenteric nodes, tonsils, liver, and spleen.",
"   </p>",
"   <p>",
"    A variety of autoimmune pathologies have also been reported in these patients, including diabetes mellitus, autoimmune hepatitis, rheumatoid arthritis, inflammatory bowel disease, and uveitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among those with AICDA and UNG deficiencies, IgG levels are generally &lt;200",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    while IgA is &lt;20",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    and IgM ranges from 100 to 3700",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    IgG specific antibody responses are nonexistent. Some patients have IgM isohemagglutinins. Numbers of T and B cells in the circulation are normal, and T cell function is intact [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Tests for both AICDA and UNG deficiency are commercially available [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AICDA and UNG deficiencies generally exhibit excellent responses to immune globulin replacement therapy with reduction in bacterial infections. Lymphoid hyperplasia is also reduced, but does not disappear in most. Treatment of autoimmune diseases requires antiinflammatory and immunosuppressive medications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/6-8,10\">",
"     6-8,10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14087?source=see_link\">",
"     \"Immune globulin therapy in primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous resolution by the age of approximately six years was reported in some patients with HIGM type IV who do not have identifiable defects or deficiency in CD40L, CD40, NEMO, UNG or AICDA [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24326/abstract/11\">",
"     11",
"    </a>",
"    ]. Patients with this type of HIGM should be reevaluated periodically to see if immune function has normalized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COMMON VARIABLE IMMUNODEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common variable immunodeficiency (CVID) is defined by low total serum concentrations of IgG, as well as low IgA",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    IgM, poor or absent response to immunization, and characteristic clinical manifestations in the absence of any other detectable molecular defect (such as XLA, hyper-IgM syndrome). CD20, CD21, and CD81 deficiencies are types of CVID. CVID is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=see_link\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/29/9688?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis of common variable immunodeficiency\", section on 'Genetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient hypogammaglobulinemia of infancy (THI) is defined as an accentuation and prolongation of the &ldquo;physiologic&rdquo; hypogammaglobulinemia of infancy that is normally observed during the first three to six months of life. The diagnosis is based upon IgG levels at least 2 SD below the mean for aged-matched controls, with or without diminished values of other Ig isotypes, that remain low beyond six months of age and occur in the absence of other immunodeficiency conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=see_link\">",
"     \"Transient hypogammaglobulinemia of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     OTHER ANTIBODY DEFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several other defects in antibody quantity or function have been identified. The classification of each of these conditions as immunodeficiencies is dependent upon a history of recurrent infections, autoimmune or gastrointestinal disorders, or other signs of impaired immune function, since entirely asymptomatic individuals with each of these abnormalities have also been identified. Thus, these conditions do not represent immunodeficient states in all people.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     IgA deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgA deficiency is a relatively common immunologic variant, which is asymptomatic in the majority of affected individuals. In a small minority, however, it can be associated with autoimmune, gastrointestinal, and atopic disorders. IgA deficiency is reviewed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=see_link\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Selective antibody deficiency with normal immunoglobulins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective antibody deficiency with normal immunoglobulins (SADNI) (also referred to as polysaccharide nonresponsiveness, polysaccharide nonresponse, impaired polysaccharide responsiveness, or specific antibody deficiency) is a condition that may exist alone, or as part of a more global immunodeficiency. It can be defined as unresponsiveness to polysaccharide antigens. Symptomatic patients with this isolated defect may have recurrent sinopulmonary infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     IgG subclass deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are four IgG subclasses: IgG1, IgG2, IgG3, and IgG4. IgG subclass deficiency is defined as the relative lack of one or more IgG subclasses, with a normal or near normal concentration of total serum IgG in a patient with recurrent severe infections. These disorders are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=see_link\">",
"     \"IgG subclass deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/16/35078?source=see_link\">",
"     \"IgG subclasses: Physical properties, genetics, and biologic functions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Selective IgM deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective deficiency of immunoglobulin M (sIgM-D) is a rare immune disorder that has been reported in association with bacteremia and other serious infections. Patients with selective IgM deficiency may be asymptomatic, have repeated infections,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    present with associated conditions, such as autoimmune, malignant, and hematologic disorders or atopic diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42168?source=see_link\">",
"     \"Selective IgM deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Selective IgE deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective IgE deficiency is defined as a level of IgE &lt;2.5",
"    <span class=\"nowrap\">",
"     IU/mL",
"    </span>",
"    in a patient whose other immunoglobulin levels and IgG subclass levels are normal. It is a laboratory finding that does not necessarily equate to a clinical disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/44/38597?source=see_link\">",
"     \"Selective IgE deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hyperimmunoglobulin-D syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hyperimmunoglobulin-D syndrome (HIDS) is a rare genetic disorder characterized by recurrent febrile episodes typically associated with lymphadenopathy, abdominal pain, and an elevated serum polyclonal IgD level. HIDS is one of several disorders involving recurrent fevers that are not due to infection. These conditions are considered autoinflammatory diseases, rather than immunodeficiencies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/43/3768?source=see_link\">",
"     \"Hyperimmunoglobulin-D syndrome: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14368569\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Humoral immune deficiency refers to diseases resulting from impaired antibody production, because of either a molecular defect intrinsic to B cells or a failure of interactions between B and T cells. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Presentation of humoral immune deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibody deficiency characteristically leads to recurrent, often severe, upper and lower respiratory tract infections with encapsulated bacteria (eg, Streptococcus pneumoniae, Haemophilus influenzae). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Presentation of humoral immune deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Findings associated with severe primary humoral immune deficiencies include failure to thrive, chronic diarrhea, recurrent fever, nodular lymphoid hyperplasia in the gut, and hepatosplenomegaly. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Presentation of humoral immune deficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of suspected primary humoral immune deficiency includes quantitative immunoglobulin levels, specific antibody titers, and enumeration of B cells and B cell subpopulations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24328?source=see_link\">",
"       \"Assessing the immunologic response to vaccination\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"       \"Laboratory evaluation of the immune system\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/1\">",
"      Notarangelo L, Casanova JL, Fischer A, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004; 114:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/2\">",
"      Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 2002; 109:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/3\">",
"      Kainulainen L, Vuorinen T, Rantakokko-Jalava K, et al. Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 2010; 126:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/4\">",
"      Wood P, Stanworth S, Burton J, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol 2007; 149:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/5\">",
"      Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol 2009; 124:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/6\">",
"      Revy P, Muto T, Levy Y, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000; 102:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/7\">",
"      Imai K, Slupphaug G, Lee WI, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003; 4:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/8\">",
"      Quartier P, Bustamante J, Sanal O, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol 2004; 110:22.",
"     </a>",
"    </li>",
"    <li>",
"     www.correlagen.com (Accessed on February 11, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/10\">",
"      Hennig C, Baumann U, Ilginus C, et al. Successful treatment of autoimmune and lymphoproliferative complications of patients with intrinsic B-cell immunodeficiencies with Rituximab. Br J Haematol 2010; 148:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24326/abstract/11\">",
"      Karaca NE, Durandy A, Gulez N, et al. Study of patients with Hyper-IgM type IV phenotype who recovered spontaneously during late childhood and review of the literature. Eur J Pediatr 2011; 170:1039.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3914 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-B1CD8C1B47-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24326=[""].join("\n");
var outline_f23_48_24326=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14368569\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRESENTATION OF HUMORAL IMMUNE DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21446846\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      X-LINKED AGAMMAGLOBULINEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      AUTOSOMAL RECESSIVE AGAMMAGLOBULINEMIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      HYPERIMMUNOGLOBULIN M SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COMMON VARIABLE IMMUNODEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TRANSIENT HYPOGAMMAGLOBULINEMIA OF INFANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      OTHER ANTIBODY DEFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      IgA deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Selective IgM deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Selective IgE deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hyperimmunoglobulin-D syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14368569\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3914\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3914|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/25/32157\" title=\"figure 1\">",
"      Serum IgG levels less than 5 y",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3914|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/33/13852\" title=\"table 1\">",
"      Lab findings immunodeficiency",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21321?source=related_link\">",
"      Agammaglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24328?source=related_link\">",
"      Assessing the immunologic response to vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/58/40873?source=related_link\">",
"      Combined immunodeficiencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=related_link\">",
"      Hyperimmunoglobulin M syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/43/3768?source=related_link\">",
"      Hyperimmunoglobulin-D syndrome: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=related_link\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/16/35078?source=related_link\">",
"      IgG subclasses: Physical properties, genetics, and biologic functions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/48/14087?source=related_link\">",
"      Immune globulin therapy in primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31098?source=related_link\">",
"      Normal B and T lymphocyte development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/29/9688?source=related_link\">",
"      Pathogenesis of common variable immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3881?source=related_link\">",
"      Protein-losing gastroenteropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=related_link\">",
"      Secondary immune deficiency due to miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=related_link\">",
"      Secondary immune deficiency induced by drugs and biologics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=related_link\">",
"      Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/44/38597?source=related_link\">",
"      Selective IgE deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42168?source=related_link\">",
"      Selective IgM deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=related_link\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=related_link\">",
"      Transient hypogammaglobulinemia of infancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_48_24327="Progression of AC arthritis on MRI";
var content_f23_48_24327=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F75836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F75836&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Progression of AC arthritis on MRI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 515px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This series of four MRI images depicts the changes seen with osteoarthritis of the acromioclavicular joint. Note the progression of joint space narrowing, subchondral cyst formation (thin arrow), and joint irregularity. The joint space in image A is indicated by the thick arrow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Scott Koehler, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24327=[""].join("\n");
var outline_f23_48_24327=null;
var title_f23_48_24328="Assessing the immunologic response to vaccination";
var content_f23_48_24328=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessing the immunologic response to vaccination",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Ricardo U Sorensen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Kenneth Paris, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24328/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24328/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/48/24328/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient's immune response to specific vaccinations serves as a correlate to their ability to fight natural infections and is essential in the assessment of the humoral immune system.",
"   </p>",
"   <p>",
"    This topic review will describe normal immunologic responses to vaccinations, patterns of abnormal responses, and methods for assessing these responses. More general evaluation of the immune system, including measurement of antibody levels and functional assessments of different immune cells, is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"     \"Primary humoral immune deficiencies: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW OF THE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the humoral immune response begins with measurement of the patient's absolute levels of IgG, IgA, and IgM and in some cases, IgE and IgG subclasses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Indications for assessing vaccine response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical indications for assessing vaccine responsiveness include frequent and recurrent sinopulmonary or otic infections, chronic gastrointestinal infections, any severe or unusual infections, and abnormal need for antibiotics (",
"    <a class=\"graphic graphic_table graphicRef60473 \" href=\"UTD.htm?2/36/2637\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Vaccine responsiveness is central to the diagnosis of several primary immunodeficiencies, including (but not limited to):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common variable immunodeficiency",
"     </li>",
"     <li>",
"      Severe combined immunodeficiency",
"     </li>",
"     <li>",
"      Hyperimmunoglobulin M syndromes",
"     </li>",
"     <li>",
"      Transient hypogammaglobulinemia of infancy",
"     </li>",
"     <li>",
"      Selective antibody deficiency with normal immunoglobulins",
"     </li>",
"     <li>",
"      IgG subclass deficiency",
"     </li>",
"     <li>",
"      Selective IgM deficiency",
"     </li>",
"     <li>",
"      Selective IgA deficiency",
"     </li>",
"     <li>",
"      Hyper IgE syndrome with recurrent infections",
"     </li>",
"     <li>",
"      Wiskott-Aldrich syndrome",
"     </li>",
"     <li>",
"      Ataxia telangiectasia",
"     </li>",
"     <li>",
"      Hypogammaglobulinemia and agammaglobulinemia (unless immunoglobulins are undetectable)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vaccine responsiveness is also utilized in the periodic evaluation of patients who were diagnosed with immune problems as children but may have outgrown their deficiencies, and in patients previously treated with gammaglobulin, in whom the original diagnosis is under question.",
"   </p>",
"   <p>",
"    Defective vaccine responses are also a feature of secondary immunodeficiency caused by various disease states, including splenic deficiency, immunosuppression, chronic lung disease, and human immunodeficiency virus (HIV) infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Types of antigens",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most evaluations of suspected immunodeficiency, the patient's ability to respond to the two main types of antigens, protein and polysaccharide antigens, should be assessed. Depending on the immunologic defect present, a patient may respond poorly to one or both.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tetanus and diphtheria are representative protein antigens to which most patients are exposed through primary vaccination. The conjugate vaccine for Hemophilus influenzae type B can also be utilized to assess immunity to protein antigens. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Conjugate vaccines'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Polysaccharide antigens include capsular polysaccharides from prevalent pathogenic strains of pneumococcus, to which patients may have been exposed through infection or vaccination. Occasionally, antibodies to polysaccharide antigens in the meningococcal vaccine can also be measured, although the \"normal\" response to these vaccines is not well-characterized.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Other antigens",
"    </span>",
"    &nbsp;&mdash;&nbsp;When patients have received gammaglobulin or other plasma products, it is possible to test for antibody responses to the bacteriophage Phi X174, which is available at specialized centers. This \"neoantigen\" is used because normal individuals have not been previously exposed to it, therefore antibodies are not present in commercially available gammaglobulin products. The use of this bacteriophage typically requires special authorization and interpretation at research institutions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Patterns of non-response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two patterns of non-response are well described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An inability to respond effectively to polysaccharide antigens only (polysaccharide non-response)",
"     </li>",
"     <li>",
"      An inability to respond effectively to both polysaccharide and protein antigens",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unusual for a patient to have an impaired response to protein antigens with a normal response to polysaccharide antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Historical information",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation begins with detailed history of past vaccinations and infectious illnesses. This is essential for proper interpretation of titers, since patients who have either had an identified infection or recently received a vaccine for that agent would be expected to have protective titers against it.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Vaccinated patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a patient has been vaccinated in the past (eg, against tetanus and diphtheria), specific titers should be measured to these antigens. If specific titers are protective as defined by the laboratory performing the measurement, then the immune response to it is normal and no further evaluation is necessary for that particular vaccine or pathogen.",
"   </p>",
"   <p>",
"    If initial titers are not protective, a single dose of the vaccine is administered and post-vaccination titers are measured no earlier than ONE MONTH after vaccination. Pre- and post-vaccination titers are then analyzed, as described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Naive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a patient has not been vaccinated against or naturally exposed to the infectious agent in question, then age-appropriate vaccination should be undertaken and the post-vaccination titers measured. Depending upon the vaccine and the age of the patient, a single injection (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    in adults) or a series of injections (eg, the primary diphtheria, tetanus, and pertussis series in children) may be indicated. Current childhood vaccination schedules are available at",
"    <a class=\"external\" href=\"file://www.cdc.gov/vaccines/recs/schedules/default.htm\">",
"     www.cdc.gov/vaccines/recs/schedules/default.htm",
"    </a>",
"    . Reviews of vaccination of children and adults are found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=see_link\">",
"     \"Standard immunizations for children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/44/41670?source=see_link\">",
"     \"Approach to immunizations in healthy adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory issues",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is critical that any evaluations of pre- and post-vaccination titers be performed by the same laboratory, because there are many variables in the techniques utilized. The same assay method should be used to process pre- and post-vaccination samples, and the assay should be standardized to WHO standards.",
"   </p>",
"   <p>",
"    Methods for the measurement of antigen-specific antibodies include nephelometry, turbidimetry, radial immunodiffusion, enzyme-linked assay, and radioimmunoassay. The method employed depends upon the laboratory and the antibody class or subclass being measured. Laboratories may determine their own reference ranges or use data provided by reagent manufacturers.",
"   </p>",
"   <p>",
"    Only IgG titers are relevant to the assessment of vaccine responses. Infections and immunizations elicit IgM, IgA, and IgG antibody responses, although only IgG antibodies confer long-term protection and are considered indicative of immunity. The IgG level represents the total of all IgG subclasses, since most antibody tests do not differentiate among Ig subclasses.",
"   </p>",
"   <p>",
"    As mentioned previously, at least ONE MONTH should be allowed between measurements of pre- and post-vaccination titers. Assessing responses earlier than this may result in low post-vaccination titers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Interfering factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immunologic response to vaccination cannot be reliably evaluated in patients who have received gammaglobulin replacement within the past eight months, or in those who have received single doses of immune globulins for prevention of specific infections (eg, hepatitis A or measles) within the past three to five months, since the antibodies assessed may be either of donor or patient origin.",
"   </p>",
"   <p>",
"    Other conditions and treatments that potentially interfere with immunoglobulin production and vaccine response include cancer, chemotherapy, and some immunosuppressive therapies (eg, long-term glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    , etc). These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link&amp;anchor=H24#H24\">",
"     \"Secondary immune deficiency induced by drugs and biologics\", section on 'Rituximab'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28249?source=see_link\">",
"     \"Glucocorticoid effects on the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     ASSESSING RESPONSE TO PROTEIN ANTIGENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tetanus and diphtheria toxoids are protein antigens. Titers of specific IgG antibodies can be measured in vaccinated children and adults to evaluate immune responsiveness to protein antigens. The antibody responses generated by these vaccines are largely (but not exclusively) composed of IgG1 and IgG3 antibodies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Tetanus and diphtheria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children normally receive the DTaP vaccine series, which contains both diphtheria and tetanus toxoids, beginning at two months of age. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5722?source=see_link&amp;anchor=H12#H12\">",
"     \"Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age\", section on 'Routine schedule'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In adults, a booster of tetanus and diphtheria is recommended every 10 years, although compliance is variable. It is therefore common to find non-protective levels, particularly to diphtheria, in healthy adults without immune problems. In a representative cross-sectional survey of individuals in the United States (US), examined between 1988 and 1994, only 47 percent of adults over the age of 20 had protective antibody titers to both organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Protective titers",
"    </span>",
"    &nbsp;&mdash;&nbsp;For both tetanus and diphtheria, antibody concentrations of &gt;0.1",
"    <span class=\"nowrap\">",
"     IU/mL",
"    </span>",
"    are usually considered indicative of long-term protection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/3\">",
"     3",
"    </a>",
"    ]. If either tetanus or diphtheria titers are protective, then the patient can be assumed to have a normal response to protein antigens. As mentioned previously, it is not uncommon for adults to have low diphtheria titers in the setting of a protective tetanus titer. A booster vaccine can be administered to confer increased protection to diphtheria, although this is not necessary for the purpose of immune evaluation.",
"   </p>",
"   <p>",
"    If a patient does not have protective titers to either tetanus or diphtheria, then a booster should be administered and titers reassessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Conjugate vaccines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conjugated vaccines contain polysaccharide antigens complexed to immunogenic proteins. These vaccines were developed because normal children under the age of two years are believed to generate weak responses to polysaccharide antigens alone. The antibody response to conjugate vaccines in young children is predominately stimulated by the protein component and therefore is not representative of either a pure polysaccharide response or a pure protein response. Therefore, in a patient who received a conjugate vaccine series, measurement of titers to the specific polysaccharides contained in the conjugate vaccine does not allow for an assessment of responsiveness to pure polysaccharide or protein antigens. Measurement of titers to the protein component, which is usually a diphtheria or tetanus toxoid, is similarly uninformative because these titers also reflect the patient's response to routine",
"    <span class=\"nowrap\">",
"     tetanus/diphtheria",
"    </span>",
"    vaccinations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pneumococcal conjugate vaccine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children in the United States have been receiving conjugated vaccines for prophylaxis against Streptococcus pneumoniae since 2001. In 2010, the 7-valent Prevnar vaccine (containing serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) was replaced in the United States by a 13-valent Prevnar vaccine. This vaccine additionally includes serotypes 1, 3, 5, 6A, 7F, and 19A. Outside the USA, 10-valent conjugate vaccines are also in use, and these vaccines include serotypes that are present in the 13-valent Prevnar. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibodies to the pneumococcal subtypes contained in the conjugate vaccine are measured after vaccination to assess protective immunity and responsiveness to protein-conjugated polysaccharide antigens. The presence of protective titers to the polysaccharides in conjugate vaccines indicates that the patient either has intact responses to conjugated polysaccharide antigens or has responded normally to natural infection.",
"   </p>",
"   <p>",
"    A serotype-specific IgG concentration &ge;1.3",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    is considered protective in all age groups. For patients who received one or more doses of the conjugate pneumococcal vaccine, at least seven serotypes present",
"    <strong>",
"     only",
"    </strong>",
"    in polysaccharide vaccine need to be measured in order to assess polysaccharide response (",
"    <a class=\"graphic graphic_table graphicRef77758 \" href=\"UTD.htm?33/12/33997\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hemophilus influenzae type B vaccine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children in the United States have been receiving conjugated vaccines for prophylaxis against Hemophilus influenzae type B (Hib) since the early 1990s. The conjugate vaccines used for immunization against Hib employ either diphtheria toxoid (Hibtiter, Lederle-Praxis; Prohibit, Connaught) or the outer membrane protein complex of meningococcus (Pedvaxhib, Merck) as the immunogenic protein. Antibodies to the Hib capsular polysaccharide, polyribosylribitol phosphate (PRP), in patients who received the conjugated Hib vaccine reflect response to conjugated polysaccharide antigens.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Protective titers - Anti-PRP IgG titers &gt;1.0",
"      <span class=\"nowrap\">",
"       microgram/mL",
"      </span>",
"      are considered protective [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ASSESSING POLYSACCHARIDE RESPONSES IN CHILDREN UNDER TWO YEARS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, pure polysaccharide vaccines are not usually used to assess immunologic function in children younger than two years of age, because even children with normal immune systems may not respond well to polysaccharide antigens, although there are preliminary data that this generalization requires further study [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Even children as young as six months of age appear to respond predictably well to certain serotypes (eg, serotype 3) and poorly to others (eg, serotype 14) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/4\">",
"     4",
"    </a>",
"    ]. Polysaccharide responsiveness normally increases with age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Isohemagglutinin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isohemagglutinins are antibodies that are normally generated in response to polysaccharides antigens from common gut bacteria. They generally appear in the blood by six months of age and can be measured in young patients who have not completed a primary vaccination series. The absence of isohemagglutinins suggests a profound defect in antibody production.",
"   </p>",
"   <p>",
"    Isohemagglutinins are so named because these antibodies cross-react with A or B blood group erythrocyte antigens [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/6\">",
"     6",
"    </a>",
"    ]. Patients with type A blood should have anti-B isohemagglutinins and patients with blood type O should have both anti-A and anti-B. Patients with type AB blood do not have isohemagglutinins under normal circumstances. These tests are usually performed by local blood banks.",
"   </p>",
"   <p>",
"    Titers of &ge;1:16 for anti-A, and &ge;1:8 for anti-B are normal. However, since this assessment measures combined titers of IgG and IgM for isohemagglutinins, it does not represent a pure IgG response to polysaccharide antigens. As a result, a normal titer does not necessarily indicate a robust polysaccharide response and therefore has limited utility.",
"   </p>",
"   <p>",
"    Although isohemagglutinins are not routinely measured by most immunologists, their absence in an infant older than six months (who has type A, B, or O blood) can signify profound immunodeficiency, such as that seen in severe combined immunodeficiency (SCID). However, the presence of isohemagglutinins does not exclude other less severe disorders, such as transient hypogammaglobulinemia of infancy or a hyper-IgM syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=see_link\">",
"     \"Transient hypogammaglobulinemia of infancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"     \"Hyperimmunoglobulin M syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ASSESSING POLYSACCHARIDE RESPONSES IN ADULTS AND CHILDREN OVER TWO YEARS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antibody response to polysaccharide antigens is predominantly composed of IgG2 molecules, with lesser amounts of IgG4. Measurement of antibody titers to various serotypes of pneumococcus is the primary means of assessing responsiveness to polysaccharide antigens in adults and in children older than two years. Rarely, the polysaccharide vaccine for meningococcus is utilized. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'Meningococcus'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Response to pneumococcal polysaccharides",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgG responses to pneumococcal serotypes in normal individuals of different ages across the general population have not been studied extensively, and so a solid definition of normal and abnormal antibody responses in different age groups is lacking. However, the approach to interpreting vaccine responses described in this section has allowed us to predict a clinical course and decide upon treatment choices in over 1000 patients of all ages tested since 1995 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Protective titers'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We recommend the measurement of sufficient different antibodies to vaccine serotypes to include at least seven serotypes present only in the 23-valent polysaccharide, as well as the serotypes found in the conjugate vaccines. This allows a reliable estimate of the spectrum of responses of a given patient. Panels of titers to different pneumococcal serotypes are available through several commercial laboratories. The table shows the serotypes that can be used to evaluate anti-polysaccharide responses to the different pneumococcal vaccines (",
"    <a class=\"graphic graphic_table graphicRef77758 \" href=\"UTD.htm?33/12/33997\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Very specific laboratory standardization rules have been developed for the measurement of anti-pneumococcal polysaccharide antibodies that include absorption of patient sera with polysaccharide C and serotype 22F. Results are expressed in",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    using a standard provided by the US Federal Drug Administration (FDA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Which serotypes to analyze",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumococcal titers can be obtained in adults and children (older than two years) who have either experienced natural pneumococcal infection, or who have received a polysaccharide vaccine in the past (Pneumovax 23, Merck; Pnu-imune 23, Lederle). In adults, titers measured within five years of receiving the polysaccharide vaccine should be accurate in most patients.",
"   </p>",
"   <p>",
"    For older children and adults who received one or more doses of the conjugate pneumococcal vaccine, at least seven serotypes present only in polysaccharide vaccine need to be measured in order to assess polysaccharide response (",
"    <a class=\"graphic graphic_table graphicRef77758 \" href=\"UTD.htm?33/12/33997\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Protective titers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A pneumococcal serotype-specific IgG concentration &ge;1.3",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    is considered protective in all age groups, as these levels have been shown to be associated with protection against infection and colonization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/8\">",
"     8",
"    </a>",
"    ]. Defining a more precise protective concentration for specific serotypes is difficult due to variations in antibody avidity and opsonizing properties that may differ with both age and serotype.",
"   </p>",
"   <p>",
"    Results are generally reported in",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    using a standard provided by the US FDA. If results are reported in ng of antibody",
"    <span class=\"nowrap\">",
"     N/mL",
"    </span>",
"    (an earlier unit system), then the conversion factor is 160 ng Ab",
"    <span class=\"nowrap\">",
"     N/mL",
"    </span>",
"    to 1",
"    <span class=\"nowrap\">",
"     micrograms/mL,",
"    </span>",
"    and protective titers are 200 to 300 ng of antibody",
"    <span class=\"nowrap\">",
"     N/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It should be noted that the &gt;1.3",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    concentration is associated with immunocompetence and protection against invasive and mucosal infections. Lower concentrations may be protective against invasive infections without documenting immunocompetence, but this has not been adequately demonstrated. The concentration of &gt;1.3",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    may not apply if different methods and standards are used, especially in countries outside the USA.",
"   </p>",
"   <p>",
"    The number of individual polysaccharide responses required for a reliable assessment of the antibody response has not been established. In our experience, the following generalizations can be made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normally vaccinated children between two and five years of age are expected to have an adequate response to &gt;50 percent of non-conjugate vaccine serotypes tested.",
"     </li>",
"     <li>",
"      Many normal adults who have never been vaccinated have protective antibodies to all or at least 70 percent of serotypes tested due to clinical or subclinical infection in the past.",
"     </li>",
"     <li>",
"      There are few studies addressing the normal immune response of older adults (&gt;65 years of age) to the polysaccharide vaccine. One study suggested that older adults make specific antibodies in similar concentrations as younger adults, but the effectiveness of these antibodies is reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/11\">",
"       11",
"      </a>",
"      ]. Another study found that frailty impacted the quantitative response to vaccines more than numerical age [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Unimmunized patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;If anti-pneumococcal titers are below protective levels in an inadequately vaccinated or unvaccinated child or adult, the patient should be given an age-appropriate vaccination(s) in order to assess vaccine response (",
"    <a class=\"graphic graphic_table graphicRef57070 \" href=\"UTD.htm?17/1/17436\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pneumococcal immunization is generally well-tolerated. However, in adult patients who have high levels of antibodies to one or a small number of serotypes, but do not have protective levels to enough of the serotypes, immunization may result in an exaggerated local reaction that can last several days. We warn such patients about the possibility of a local reaction before administering the vaccine, and treat these reactions with nonsteroidal antiinflammatory medications when they occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Pre- and post-vaccination titers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccination is performed if a patient's pre-existing titers are not protective. The patient's response is deemed adequate if an age-dependent percentage of the serotype-specific post-vaccination titers are protective [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A serotype specific IgG titer is considered protective if the value is &ge;1.3",
"      <span class=\"nowrap\">",
"       micrograms/mL.",
"      </span>",
"     </li>",
"     <li>",
"      Patients two to five years of age should be able to generate protective titers to at least 50 percent of the serotypes administered.",
"     </li>",
"     <li>",
"      Patients six years of age and older should be able to generate protective titers to at least 70 percent of the serotypes administered.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Deficient responses are therefore defined as lower percentages of protective titers, as shown in the table (",
"    <a class=\"graphic graphic_table graphicRef77185 \" href=\"UTD.htm?25/31/26107\">",
"     table 4",
"    </a>",
"    ). A deficient vaccine response can be classified as severe or moderate.",
"   </p>",
"   <p>",
"    Previously, the ratio of post- to pre-vaccination titer was also considered. However, this approach is no longer recommended. Patients who already have protective antibody concentrations and are vaccinated (either again or for the first time), are less likely to have a significant increase in antibody concentrations after immunization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. As an example, the likelihood of achieving a fourfold increase for a specific serotype decreases as the pre-immunization titer increases, and at levels between approximately 4 and 10",
"    <span class=\"nowrap\">",
"     micrograms/mL",
"    </span>",
"    (depending on the serotype) very few patients will demonstrated a fourfold increase [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/16\">",
"     16",
"    </a>",
"    ]. Therefore, it is not recommended that patients with adequate titers receive additional doses of vaccine for the purpose of assessing response.",
"   </p>",
"   <p>",
"    There is no response to a single serotype-specific polysaccharide that predicts the ability to or inability to respond to most or all other serotypes (ie, responses to all serotypes are considered equally).",
"   </p>",
"   <p>",
"    Some patients who initially develop an adequate antibody response demonstrate a rapid decline in antibody titers over the ensuing year and remain susceptible to pneumococcal infections. Thus, retesting of antibody titers after 6 to 12 months may be indicated to determine if a patient's titers have dropped to below protective levels in this time period. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Additional doses",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the majority of patients who do not develop protective titers to the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    , repeat or \"booster\" doses are not recommended in assessing vaccine responsiveness. The normal response to a \"booster\" dose has not been studied, and it is our experience that most patients who do not respond to the polysaccharide vaccine initially, also do not respond significantly to repeat doses either [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are two possible exceptions to the above generalization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Young patients (two to five years of age) who demonstrated a poor response to the polysaccharide vaccine sometimes have a more vigorous response to a repeat dose given one to two years later. This probably represents slightly delayed maturation of the immune system.",
"     </li>",
"     <li>",
"      Older patients with post-vaccination titers that are slightly below protective levels, and who are otherwise immunologically normal, sometimes develop protective titers after an additional dose of vaccine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Meningococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polysaccharide meningococcal vaccine, instead of pneumococcal vaccine, may be used to assess polysaccharide response in rare cases where other polysaccharide vaccines are contraindicated, such as prior history of anaphylaxis to vaccine components.",
"   </p>",
"   <p>",
"    Titers to the antigenic polysaccharides of meningococcus (polysaccharides A and C) can be measured in patients older than two years of age who have been given a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38965?source=see_link\">",
"     meningococcal polysaccharide vaccine",
"    </a>",
"    <span class=\"nowrap\">",
"     (Menomune&reg;-A/C/Y/W-135;",
"    </span>",
"    Aventis Pasteur). Titers can be obtained after vaccination and normally remain detectable for approximately three to four years. This vaccine is not routinely given in the United States and the interpretation of post-vaccination meningococcal titers as a measure of immunocompetence is not well established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=see_link\">",
"     \"Meningococcal vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DISORDERS ASSOCIATED WITH PATTERNS OF VACCINE RESPONSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various types of impaired vaccine responses are discussed briefly in this section with links to more detailed reviews of specific disorders. There are two commonly-encountered patterns of vaccine non-response: combined non-response to protein and polysaccharide antigens, and non-response to polysaccharide antigens only. Other patterns are unusual.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Protein and polysaccharide non-response",
"    </span>",
"    &nbsp;&mdash;&nbsp;This combined type of non-response is indicative of profound immune defects, and is seen in the following disorders:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common variable immunodeficiency (CVID) - CVID is characterized by hypogammaglobulinemia and recurrent sinopulmonary infections, chronic diarrhea, and an enhanced risk of malignancy, granulomatous disease, and joint involvement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=see_link\">",
"       \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Severe combined immunodeficiency (SCID) - The SCID syndromes are a heterogeneous group of disorders arising from a disturbance in the development and function of both T and B cells. As a result, both cellular and humoral immunity are severely impaired. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"       \"Severe combined immunodeficiency (SCID): An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyper-IgM syndromes - Hyper-IgM syndromes are characterized by selective deficiency of IgG, very poor specific vaccine responses, and normal or elevated serum concentrations of IgM. Isohemagglutinins are sometimes present. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=see_link\">",
"       \"Hyperimmunoglobulin M syndromes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Polysaccharide non-response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated polysaccharide non-response with intact protein response is seen in several primary immune disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Selective antibody deficiency with normal immunoglobulins (sometimes called polysaccharide non-response) &mdash; This disorder is characterized by normal levels of serum immunoglobulins and IgG subclasses, recurrent sinopulmonary infections, and impaired response to polysaccharide antigens. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"       \"Selective antibody deficiency with normal immunoglobulins\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IgG subclass deficiency - IgG subclass deficiencies are a group of disorders characterized by normal levels of IgG, IgA, and IgM, but low levels of one or more IgG subclasses, recurrent sinopulmonary infections, and impaired response to vaccination. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=see_link\">",
"       \"IgG subclass deficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IgA deficiency - The finding of polysaccharide non-responsiveness in young patients determined to have IgA deficiency may represent a presentation of an evolving CVID phenotype, rather than isolated IgA deficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=see_link\">",
"       \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Agammaglobulinemia and hypogammaglobulinemia - These disorders are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"       \"Primary humoral immune deficiencies: An overview\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Non-response to conjugate polysaccharides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to respond to the pneumococcal conjugate vaccine has been observed regularly by the author and others. The etiology and clinical implications of this finding are currently under investigation. Some of these patients subsequently respond to immunization with the polysaccharide vaccine, while others do not. Some patients with selective antibody deficiency with normal immunoglobulins (polysaccharide non-response) have also been reported to be unresponsive to an initial dose of conjugate pneumococcal vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24328/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Normal vaccine response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific antibody measurements and vaccine challenge is an essential component of the diagnosis of transient hypogammaglobulinemia of infancy (THI). In THI, vaccine responses are normal or nearly normal. This disorder has been classically defined as an accentuation and prolongation of the &ldquo;physiologic&rdquo; hypogammaglobulinemia of infancy, which is normally observed during the first three to six months of life. Patients present with recurrent sinopulmonary and sometimes more severe infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=see_link\">",
"     \"Transient hypogammaglobulinemia of infancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The evaluation of a patient's immune response to specific vaccinations serves as a correlate to their ability to fight natural infections and is a component of the diagnosis of several primary and secondary immunodeficiencies. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical indications for assessing vaccine response (and the humoral immune system) include frequent and recurrent sinopulmonary or otic infections, chronic gastrointestinal infections, any severe or unusual infections, and abnormal need for antibiotics (",
"      <a class=\"graphic graphic_table graphicRef60473 \" href=\"UTD.htm?2/36/2637\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications for assessing vaccine response'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Response to both protein (eg, tetanus and diphtheria) and polysaccharide (eg, pneumococcal) antigens should be assessed. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Types of antigens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A minimum duration of one month should elapse between vaccination and measurement of response, for most vaccines.",
"     </li>",
"     <li>",
"      There are two well-described patterns of non-response to vaccines: an inability to respond effectively to polysaccharide antigens only (polysaccharide non-response), and an inability to respond effectively to both polysaccharide and protein antigens. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Patterns of non-response'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibodies to tetanus and diphtheria toxoids can be measured in vaccinated children and adults to evaluate responsiveness to protein antigens. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Assessing response to protein antigens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The assessment of responsiveness to polysaccharide antigens is influenced by the patient's age. It is not possible to assess a pure response to polysaccharide antigens in a child under two years of age, because even children with normal immune systems do not respond well to pure polysaccharide antigens. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Assessing polysaccharide responses in children under two years'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In adults and children older than two years, response to polysaccharide antigens can be evaluated by measuring at least 14 serotypes to pneumococcal polysaccharides (",
"      <a class=\"graphic graphic_table graphicRef77758 \" href=\"UTD.htm?33/12/33997\">",
"       table 2",
"      </a>",
"      ). In patients who received the conjugate vaccine, titers to serotypes in that vaccine are NOT relevant to polysaccharide responsiveness. Criteria for adequate responses have been proposed (",
"      <a class=\"graphic graphic_table graphicRef77185 \" href=\"UTD.htm?25/31/26107\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      If an age-appropriate percentage of titers are protective (&ge;1.3",
"      <span class=\"nowrap\">",
"       micrograms/mL),",
"      </span>",
"      then the patient can respond to polysaccharide antigens and no further evaluation is needed.",
"     </li>",
"     <li>",
"      If an age-appropriate percentage of titers are NOT protective, then the patient should be vaccinated with the polysaccharide vaccine and titers repeated no earlier than one month later. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Assessing polysaccharide responses in adults and children over two years'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two commonly-encountered patterns of vaccine non-response: combined non-response to protein and polysaccharide antigens, and non-response to polysaccharide antigens only. The former is characteristic of more global immune deficiencies (eg, SCID, CVID) and the latter, of less severe problems (eg, selective antibody deficiency with normal immunoglobulins, IgG subclass deficiencies). Normal vaccine responses are typical of transient hypogammaglobulinemia of infancy. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Disorders associated with patterns of vaccine response'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/1\">",
"      Ochs HD, Buckley RH, Kobayashi RH, et al. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood 1992; 80:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/2\">",
"      McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002; 136:660.",
"     </a>",
"    </li>",
"    <li>",
"     www.aruplab.com (Accessed on May 01, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/4\">",
"      Bossuyt X, Borgers H, Moens L, et al. Age- and serotype-dependent antibody response to pneumococcal polysaccharides. J Allergy Clin Immunol 2011; 127:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/5\">",
"      Licciardi PV, Balloch A, Russell FM, et al. Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses. J Allergy Clin Immunol 2012; 129:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/6\">",
"      Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 1974; 14:551.",
"     </a>",
"    </li>",
"    <li>",
"     Sorensen RU, et al, unpublished observations.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/8\">",
"      Sorensen RU, Leiva LE, Giangrosso PA, et al. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998; 17:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/9\">",
"      Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981; 3 Suppl:S184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/10\">",
"      Lawrence EM, Edwards KM, Schiffman G, et al. Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child 1983; 137:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/11\">",
"      Schenkein JG, Park S, Nahm MH. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 2008; 26:5521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/12\">",
"      Ridda I, Macintyre CR, Lindley R, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009; 27:1628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/13\">",
"      Zielen S, B&uuml;hring I, Strnad N, et al. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine. Infect Immun 2000; 68:1435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/14\">",
"      Balloch A, Licciardi PV, Russell FM, et al. Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine. J Allergy Clin Immunol 2010; 126:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/15\">",
"      Sorensen RU, Leiva LE, Javier FC 3rd, et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 1998; 102:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/16\">",
"      Hare ND, Smith BJ, Ballas ZK. Antibody response to pneumococcal vaccination as a function of preimmunization titer. J Allergy Clin Immunol 2009; 123:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/17\">",
"      Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol 2007; 99:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24328/abstract/18\">",
"      Shrimpton A, Duddridge M, Ziegler-Heitbrock L. Vaccination with polysaccharide-conjugate-vaccines in adult patients with specific antibody deficiency. Vaccine 2006; 24:3574.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3929 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-202.43.93.2-77D3A94D3A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24328=[""].join("\n");
var outline_f23_48_24328=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW OF THE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Indications for assessing vaccine response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Types of antigens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Other antigens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Patterns of non-response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Historical information",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Vaccinated patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Naive patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory issues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Interfering factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      ASSESSING RESPONSE TO PROTEIN ANTIGENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Tetanus and diphtheria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Protective titers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Conjugate vaccines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pneumococcal conjugate vaccine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hemophilus influenzae type B vaccine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ASSESSING POLYSACCHARIDE RESPONSES IN CHILDREN UNDER TWO YEARS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Isohemagglutinin testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ASSESSING POLYSACCHARIDE RESPONSES IN ADULTS AND CHILDREN OVER TWO YEARS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Response to pneumococcal polysaccharides",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Which serotypes to analyze",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Protective titers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Unimmunized patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Pre- and post-vaccination titers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Additional doses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Meningococcus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DISORDERS ASSOCIATED WITH PATTERNS OF VACCINE RESPONSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Protein and polysaccharide non-response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Polysaccharide non-response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Non-response to conjugate polysaccharides",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Normal vaccine response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3929\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3929|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/36/2637\" title=\"table 1\">",
"      Clinical indications of possible antibody defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/12/33997\" title=\"table 2\">",
"      Pneu vaccine antibody testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/1/17436\" title=\"table 3\">",
"      Pneu vaccine patients rec infec",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/31/26107\" title=\"table 4\">",
"      Diagnosis of anti poly def",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/44/41670?source=related_link\">",
"      Approach to immunizations in healthy adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5722?source=related_link\">",
"      Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28249?source=related_link\">",
"      Glucocorticoid effects on the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/32/21001?source=related_link\">",
"      Hyperimmunoglobulin M syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/60/13258?source=related_link\">",
"      IgG subclass deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/32/23050?source=related_link\">",
"      Meningococcal vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=related_link\">",
"      Secondary immune deficiency induced by drugs and biologics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=related_link\">",
"      Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=related_link\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/36/41544?source=related_link\">",
"      Transient hypogammaglobulinemia of infancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_48_24329="Clinical features and diagnosis of leptomeningeal metastases from solid tumors";
var content_f23_48_24329=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of leptomeningeal metastases from solid tumors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Alexis Demopoulos, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Jerome B Posner, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Jay S Loeffler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/48/24329/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/48/24329/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/48/24329/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leptomeningeal metastases (carcinomatous meningitis) are a rare but frequently devastating complication of advanced cancer. Patients can present with a broad range of signs and symptoms due to involvement of multiple areas of the craniospinal axis. Diagnosis often requires a high index of suspicion and is confirmed by neuroimaging and cerebrospinal fluid analysis.",
"   </p>",
"   <p>",
"    The pathophysiology, clinical manifestations, and diagnosis of leptomeningeal metastases (LM) from solid tumors will be reviewed here. The treatment of LM and leptomeningeal involvement in hematologic malignancies, especially large cell lymphomas and acute leukemias, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26458?source=see_link\">",
"     \"Treatment of leptomeningeal metastases (carcinomatous meningitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link&amp;anchor=H7#H7\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\", section on 'Leptomeningeal disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25607?source=see_link\">",
"     \"Involvement of the central nervous system with acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leptomeningeal metastases (LM) are diagnosed in approximately 5 percent of patients with metastatic cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1-3\">",
"     1-3",
"    </a>",
"    ], but undiagnosed or asymptomatic involvement is more common [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/4-10\">",
"     4-10",
"    </a>",
"    ]. At autopsy, the frequency of LM averages 20 percent and is much higher with some tumor types [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/2,11,12\">",
"     2,11,12",
"    </a>",
"    ]. Co-existing brain metastases are present in 50 to 80 percent of patients in modern series [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/13-17\">",
"     13-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common solid tumors giving rise to LM are breast cancer (12 to 35 percent), lung cancer (10 to 26 percent), melanoma (5 to 25 percent), gastrointestinal malignancies (4 to 14 percent), and cancers of unknown primary (1 to 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1-3,13\">",
"     1-3,13",
"    </a>",
"    ]. In women with breast cancer, infiltrating lobular carcinoma has a particular predilection to metastasize to the leptomeninges [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Primary brain tumors, including low- and high-grade astrocytomas, medulloblastomas, ependymomas, pineoblastomas, and oligodendrogliomas, can infiltrate the leptomeninges or disseminate along cerebrospinal fluid (CSF) pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of LM may also be influenced by treatment:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improved treatment strategies for systemic cancers that lead to longer survival (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       trastuzumab",
"      </a>",
"      in HER2-positive breast cancer) may increase the risk of developing central nervous system (CNS) metastases, including LM [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/23-26\">",
"       23-26",
"      </a>",
"      ]. In some cases the blood-brain barrier likely creates a sanctuary site, where malignant cells are shielded from systemic therapy.",
"     </li>",
"     <li>",
"      Surgical resection of cerebellar metastases has been associated with increased risk of subsequent LM, presumably due to spillage of malignant cells into the CSF [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/27,28\">",
"       27,28",
"      </a>",
"      ]. The risk appears to be greater after piecemeal resection of metastases compared with en bloc resections for both posterior fossa and supratentorial brain metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/29-31\">",
"       29-31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three membranes surrounding the brain and spinal cord: the dura mater, the arachnoid, and the pia mater. The dura mater is also referred to as the pachymeninges, and the inner two layers are called the leptomeninges. The subarachnoid space lies between the arachnoid and pia mater and contains the cerebrospinal fluid (CSF) and arteries supplying the brain parenchyma. Tumor involvement of the leptomeninges, which is distinguished from tumor involving the dura, is associated with spread of malignant cells throughout the subarachnoid space.",
"   </p>",
"   <p>",
"    The total CSF volume in adults is approximately 140 mL, and the entire volume is replaced more than five times daily. The physiology of CSF formation and flow is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=see_link\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Tumor cells can gain access to the CSF in several ways (",
"    <a class=\"graphic graphic_figure graphicRef78434 \" href=\"UTD.htm?32/23/33144\">",
"     figure 1",
"    </a>",
"    ). Hematogenous spread via the arachnoid vessels or direct extension from the brain parenchyma are likely the most common means. Other possible routes include spread from choroid plexus metastases into the CSF, direct extension from vertebral, subdural, or epidural metastases, retrograde invasion along peripheral or cranial nerves to the subarachnoid space, and rare",
"    <em>",
"     de novo",
"    </em>",
"    tumors arising in the meninges, including lymphoma, melanoma, and several sarcomas (eg, malignant peripheral nerve sheath tumors).",
"   </p>",
"   <p>",
"    The clinical manifestations of LM can be caused by several different pathophysiologic mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mass effect, due to invasion of the leptomeninges and associated inflammation, occluding CSF flow; this can lead to hydrocephalus or, less often, increased intracranial pressure (ICP) without hydrocephalus.",
"     </li>",
"     <li>",
"      Cranial nerve and spinal nerve root dysfunction, caused by direct tumor involvement.",
"     </li>",
"     <li>",
"      Invasion of the brain parenchyma by tumor cells, usually via the Virchow-Robin spaces. Symptoms are then caused by interference with the cerebrovascular circulation or competition with brain cells for essential metabolites, including glucose and oxygen.",
"     </li>",
"     <li>",
"      Disruption of the blood-brain barrier, causing cerebral edema.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common sites of gross tumor involvement are the base of the brain (basilar cisterns or posterior fossa), the sylvian fissures, and the cauda equina, probably due to the relatively slow flow of CSF through these areas and the effect of gravity. Tumor cells may also invade the spinal or cranial nerves, cerebral cortex, or spinal cord via the Virchow-Robin spaces (",
"    <a class=\"graphic graphic_picture graphicRef65372 \" href=\"UTD.htm?27/51/28471\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with leptomeningeal metastases (LM) typically present relatively acutely, with symptoms emerging over days to weeks. Most patients present with both focal and diffuse neurological signs and symptoms, indicative of multilevel involvement. Neuroimaging typically shows linear",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nodular enhancement of the leptomeninges, cranial nerves and spinal nerve roots, including the cauda equina. Cerebrospinal fluid (CSF) is usually abnormal, with decreased glucose, elevated protein, increased numbers of lymphocytes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    positive cytology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7302347\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifocal involvement is a hallmark of leptomeningeal disease. Although patients may present with a single symptom, careful neurologic evaluation often reveals additional sites of neurologic dysfunction. As an example, a patient complaining of diplopia may have an absent Achilles tendon reflex. The specific clinical symptoms and signs vary, depending upon the site of leptomeningeal invasion and their mechanism.",
"   </p>",
"   <p>",
"    In a series of 150 patients with solid tumor LM, the most common presenting signs and symptoms were headache (39 percent), nausea and vomiting (25 percent), leg weakness (21 percent), cerebellar dysfunction (17 percent), altered mental status (16 percent), diplopia (14 percent), and facial weakness (13 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/13,32\">",
"     13,32",
"    </a>",
"    ]. In the same series, 34 percent of patients presented with symptoms localized to one compartment (cerebral, posterior fossa, or spine), 39 percent to two compartments, and 25 percent to all three. Only two patients (1 percent) with solid tumor LM were asymptomatic at the time of diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008145\">",
"    <span class=\"h3\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;Headache is the most common initial symptom of LM, present in 30 to 50 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. Headache can be caused by increased intracranial pressure (ICP) or meningeal irritation, and it is sometimes difficult to distinguish the two. Asking about other symptoms associated with the headache can help:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nausea, vomiting, and dizziness accompanying headache suggest increased ICP, with or without associated hydrocephalus. The symptoms may increase in association with the production of plateau waves, often triggered by changes in position (eg, sitting to standing). Funduscopic exam may show papilledema. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=see_link\">",
"       \"Evaluation and management of elevated intracranial pressure in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Headache accompanied by neck pain or stiffness and exacerbated by head movements is more characteristic of meningeal irritation. In addition, pain with straight leg raising can also suggest spinal meningeal irritation. &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008198\">",
"    <span class=\"h3\">",
"     Altered mental status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of confusion, forgetfulness, disorientation, subtle personality changes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lethargy, collectively referred to as encephalopathy or altered mental status, are common in patients with LM and can be secondary to diffuse cerebral dysfunction, hydrocephalus, seizures, or a combination. Encephalopathy in isolation, without other focal signs or symptoms, is uncommon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008206\">",
"    <span class=\"h3\">",
"     Cranial neuropathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cranial neuropathies are caused by invasion of the cranial nerves within the subarachnoid space [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/11,33\">",
"     11,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diplopia is the most common cranial nerve symptom of LM [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/4,14,32\">",
"       4,14,32",
"      </a>",
"      ]. Dysfunction of any of the cranial nerves supplying the extraocular muscles (ie, the oculomotor (III), trochlear (IV) or abducens (VI) nerves) can cause it. The history and exam can help localize diplopia to one or more cranial nerves. As an example, side-by-side or horizontal diplopia that is present on distance and lateral gaze is characteristic of an abducens palsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25320?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of diplopia\", section on 'Presentation/history'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Facial pain, paresthesias and numbness can indicate involvement of the trigeminal nerve. One specific form of facial numbness, the \"numb chin syndrome,\" can be a presenting symptom of LM disease, although it is more frequently due to bony mandibular metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/11\">",
"       11",
"      </a>",
"      ]. In one series of 42 patients, numb chin syndrome was the presenting symptom of LM in 22 percent of cases and often preceded the diagnosis of recurrent cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Facial weakness secondary to involvement of the facial nerve is manifested by weakness of both the upper face (ie, difficulty closing the eye completely, decreased eyebrow raise) and the lower face.",
"     </li>",
"     <li>",
"      Unilateral or bilateral sensorineural hearing loss is an infrequent presenting symptom of LM disease (&lt;5 percent) but becomes more common as the disease progresses.",
"     </li>",
"     <li>",
"      Dysarthria, dysphagia or hoarseness can be symptoms of lower cranial nerve dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008420\">",
"    <span class=\"h3\">",
"     Cerebellar dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gait instability, difficulty walking, dizziness and falls referable to cerebellar dysfunction are present in approximately 20 percent of patients at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,13\">",
"     1,13",
"    </a>",
"    ]. Both midline cerebellar symptoms (eg, gait ataxia) and lateral cerebellar symptoms (eg, limb dysmetria) can be seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008428\">",
"    <span class=\"h3\">",
"     Radiculopathy and cauda equina syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal nerve root involvement may cause radicular pain, numbness or muscle weakness in the anatomic distribution of the involved level (",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"UTD.htm?21/8/21634\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50419 \" href=\"UTD.htm?10/36/10822\">",
"     figure 3",
"    </a>",
"    ).Most commonly, the roots of the cauda equina supplying the lower extremities, bowels, and bladder are affected, but roots in the thoracic and cervical spinal cord can also be involved. Cauda equina involvement can be manifested as leg pain, leg weakness or numbness, urinary incontinence or retention,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    an asymmetry of deep tendon reflexes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5832?source=see_link&amp;anchor=H22#H22\">",
"     \"Anatomy and localization of spinal cord disorders\", section on 'Cauda equina syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14570?source=see_link\">",
"     \"Polyradiculopathy: spinal stenosis, infectious, carcinomatous, and inflammatory nerve root syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008445\">",
"    <span class=\"h3\">",
"     Seizures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Partial seizures with or without secondary generalization can be caused by cortical irritation from adjacent LM deposits, invasion of brain parenchyma, or local edema. Seizures have been reported in up to 25 percent of patients with LM [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,14\">",
"     1,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H263250910\">",
"    <span class=\"h3\">",
"     Plateau waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dizziness, lightheadedness, presyncope, or even frank syncope, typically associated with positional changes (ie, sitting to standing), can be symptomatic of plateau waves in the setting of increased ICP or venous obstruction, even in the absence of headache. Evidence of increased ICP (eg, papilledema, hydrocephalus on imaging studies) should be sought. Not infrequently, no ventricular enlargement is seen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1008478\">",
"    <span class=\"h3\">",
"     Other symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal cortical signs and symptoms such as hemiparesis, aphasia or visual field defects can be caused by invasion of brain parenchyma or more rarely focal ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/37\">",
"     37",
"    </a>",
"    ]. Panhypopituitarism or diabetes insipidus can result from leptomeningeal invasion of the pituitary stalk, although this is more common in leukemic than solid tumor LM.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7301458\">",
"    <span class=\"h2\">",
"     Neuroimaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gadolinium-enhanced magnetic resonance imaging (MRI) of the brain and spine often provides important evidence of LM. Although MRI probably is more sensitive (76 to 87 percent in multiple studies) than a single CSF specimen for cytology, it is less specific because false positive cytologies are rare (see",
"    <a class=\"local\" href=\"#H7301492\">",
"     'Cytology'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/38-41\">",
"     38-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients who cannot undergo MRI, computed tomography (CT) with contrast can demonstrate similar findings, albeit with lower sensitivity than MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1009751\">",
"    <span class=\"h3\">",
"     Brain MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical brain MRI findings of LM include thin, diffuse leptomeningeal contrast enhancement following the contours of the gyri and sulci or multiple nodular deposits in the subarachnoid space. Common sites of abnormal leptomeningeal enhancement are the cerebellar folia (often best visualized on coronal post-contrast images) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87762 \" href=\"UTD.htm?36/26/37286\">",
"     image 1",
"    </a>",
"    ), the cortical surface, and the basal cisterns, particularly along the ventral surface of the brainstem (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87763 \" href=\"UTD.htm?17/39/18036\">",
"     image 2",
"    </a>",
"    ). In addition, the cisternal segments of the cranial nerves may be abnormally thickened and enhancing. High-resolution contrast-enhanced skull base MRI can sometimes show cranial nerve abnormalities that are not seen on routine MRI. Fluid-attenuated inversion recovery (FLAIR) images may show hyperintensity within the subarachnoid space, indicative of high protein content [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Any or all of these findings may be accompanied by ventriculomegaly in the absence of, or out of proportion to, the degree of sulcal enlargement (ie, hydrocephalus). In the elderly and in patients previously treated with whole brain radiation, it can sometimes be difficult to distinguish hydrocephalus from ex vacuo enlargement of the ventricles. Imaging findings that suggest true hydrocephalus include abnormal periventricular T2 hyperintensity (suggesting transependymal CSF absorption) and sulcal effacement (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef87728 \" href=\"UTD.htm?17/5/17494\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Occasionally, frank leptomeningeal enhancement is not seen on MRI, but bulky subependymal disease or multiple small sulcal metastases suggest the diagnosis.",
"   </p>",
"   <p>",
"    In patients who are being treated with the antiangiogenic agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    , the diagnosis may be more difficult because neuroimaging features may be altered [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/43\">",
"     43",
"    </a>",
"    ]. Leptomeningeal enhancement may be minimal or absent, and the observed abnormalities may suggest vasculitis or small vessel vasculopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1009758\">",
"    <span class=\"h3\">",
"     Spine MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the spinal cord, MRI can show linear or nodular enhancement along the surface of the cord and linear or nodular enhancement of the cauda equina (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58160 \" href=\"UTD.htm?39/13/40146\">",
"     image 4",
"    </a>",
"    ). Occasionally, clumping of nerve roots at the cauda equina suggests the diagnosis even if contrast enhancement is not seen. Rarely, a leptomeningeal spinal tumor may obstruct CSF flow, resulting in hydrocephalus without any discrete tumor masses in the leptomeninges of the brain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7301485\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic CSF findings of LM include a high opening pressure, low glucose concentration, high protein concentration, lymphocytic pleocytosis, and positive cytology for malignant cells. Although most patients do not have all of these features, an entirely normal CSF examination is uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,4,44,45\">",
"     1,4,44,45",
"    </a>",
"    ]. As an example, in one large series, only 5 out of 104 patients with LM had completely normal basic CSF parameters; of these, 4 had breast cancer and 1 had leukemia. The most common CSF profile is a combination of high protein concentration and lymphocytic pleocytosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=see_link\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1009947\">",
"    <span class=\"h3\">",
"     Basic parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each one of the four basic CSF parameters (opening pressure, cell count with differential, total protein, and glucose) can be affected by the presence of LM.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An elevated opening pressure above 16 cm H2O is common and probably underreported. As an example, in a study of 187 patients with LM at a single center over a two-year period, opening pressure was only measured in 32 patients, of whom 50 percent had values &gt; 20 cm H2O [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mild elevation of the white blood cell count is seen in 50 to 60 percent of patients. The white cells are usually lymphocytes, although eosinophilia is seen with recurrent acute lymphoblastic leukemia and Hodgkin lymphoma [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Xanthochromia, a result of bleeding into the CSF, is common with melanoma but rare in other tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The CSF protein concentration is elevated (&gt;38",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      in 60 to 80 percent of cases, mainly as the result of blood brain barrier breakdown, although tumor protein production may also contribute [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,13\">",
"       1,13",
"      </a>",
"      ]. Very high protein levels suggest blockage of CSF flow and may be associated with a paucity of CSF fluid obtained during the procedure (\"dry tap\").",
"     </li>",
"     <li>",
"      The CSF glucose concentration is decreased (CSF:serum ratio &lt;0.6) in about 30 percent of cases, the result of either impaired transport or increased metabolism by tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/1,13\">",
"       1,13",
"      </a>",
"      ]s.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7301492\">",
"    <span class=\"h3\">",
"     Cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definitive diagnostic finding for LM is the cytologic identification of malignant cells within the CSF (",
"    <a class=\"graphic graphic_picture graphicRef55757 \" href=\"UTD.htm?24/26/25007\">",
"     picture 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/9,44\">",
"     9,44",
"    </a>",
"    ]. The specificity of CSF cytology is very high, since false-positive results are rare in the hands of experienced cytopathologists [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, the sensitivity of cytology is only between 80 and 95 percent, and false-negative results can be a source of frustration for clinicians and patients, necessitating repeat lumbar punctures and delaying therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/4,44,48\">",
"     4,44,48",
"    </a>",
"    ]. Specific recommendations to minimize false-negative results include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A minimum of 10 mL of CSF should be withdrawn with each sample solely for cytologic analysis.",
"     </li>",
"     <li>",
"      Specimens must be processed promptly, including immediate fixation in ethanol-based fixative for cytology. Specimens should not sit overnight before being fixed, even if refrigerated.",
"     </li>",
"     <li>",
"      LP should be repeated if the initial cytology is negative but clinical suspicion is high, particularly if basic indices are abnormal (eg, high protein or pleocytosis).",
"     </li>",
"     <li>",
"      CSF obtained closest to the site of symptoms (ie, intraventricularly or by cervical spine puncture under fluoroscopic guidance for cranial symptoms and LP for spinal root dysfunction) may have the highest yield [",
"      <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/45\">",
"       45",
"      </a>",
"      ]. CSF drawn from an indwelling ventricular access device (eg, an Ommaya catheter) may yield very different results than CSF drawn from a lumbar puncture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal number of samples is uncertain. In a compilation of data from nine reports including 532 patients, the rates of positive cytology were 71, 86, 90, and 98 percent for one, two, three, or more than three samples per patient [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/44\">",
"     44",
"    </a>",
"    ]. However, these series varied according to the volume of CSF withdrawn, specimen processing, and whether or not intervening treatment had been administered. In most cases, a positive cytology can be obtained with two separate samplings totaling at least 30 mL, with little if any benefit gained from additional specimens.",
"   </p>",
"   <p>",
"    Despite these measures, CSF cytology is persistently negative in as many up to 20 percent of patients with clinically or radiographically unequivocal LM [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/13,44\">",
"     13,44",
"    </a>",
"    ]. The reason for negative CSF cytology in such patients is unclear; presumably, the malignant cells adhere to the leptomeninges rather than float in the CSF. In these cases, the diagnosis can be made in the appropriate clinical context by neuroimaging alone [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Diagnostic evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Immunohistochemical staining of cells in the cytologic specimen is sometimes possible and may provide diagnostic information or suggest the primary site in a patient with an unknown primary [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7301581\">",
"    <span class=\"h3\">",
"     Flow cytometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;CSF flow cytometry or other molecular studies may be particularly valuable in diagnosing LM from hematologic malignancies. Flow cytometry is not generally indicated for the evaluation of suspected LM disease from solid tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link&amp;anchor=H7#H7\">",
"     \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\", section on 'Leptomeningeal disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25607?source=see_link\">",
"     \"Involvement of the central nervous system with acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1010278\">",
"    <span class=\"h3\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumor markers (eg, CEA, PSA, CA-15-3, CA-125, and MART-1 and MAGE-3 in melanoma) may provide evidence for CSF dissemination of disease, even when serial cytological evaluations are negative (",
"    <a class=\"graphic graphic_table graphicRef81558 \" href=\"UTD.htm?35/56/36747\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/2,48,50-60\">",
"     2,48,50-60",
"    </a>",
"    ]. Concentrations of CSF tumor markers that are more than 2 to 3 percent of simultaneous serum values are unlikely to be due to serum contamination or simple diffusion across the blood-brain barrier, unless the CSF albumin concentration is also very high (&gt;100",
"    <span class=\"nowrap\">",
"     mg/dL),",
"    </span>",
"    indicating disruption of the blood-brain barrier. If the concentration of biochemical tumor markers within the CSF is greater than the serum concentration, then neoplastic meningitis is almost certain, even in the face of negative cytology.",
"   </p>",
"   <p>",
"    Novel biochemical markers implicated in tumor invasion, angiogenesis, and metastasis (eg, vascular endothelial growth factor, matrix metalloproteinases, and lipid-associated sialic acid) are promising diagnostically but more data are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/60-65\">",
"     60-65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363877\">",
"    <span class=\"h3\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Techniques for identifying circulating tumor cells (CTCs) in peripheral blood can be modified for CSF samples with good preliminary sensitivity; such testing is not yet widely available commercially [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/66-68\">",
"     66-68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3473096\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients suspected of having leptomeningeal metastases (LM) should initially undergo a complete history and physical examination. The history should pay specific attention to subtle symptoms suggestive of multifocal involvement. The physical examination should include a detailed neurological examination, which may reveal findings not suggested by the history.",
"   </p>",
"   <p>",
"    Next, we perform MRI of the brain and spine in all patients with suspected LM. If a routine brain MRI is normal and clinical suspicion is high, a high-resolution contrast-enhanced skull base MRI should be considered, as this may highlight subtle enhancement of the cranial nerves not appreciated on routine sequences (and may provide an alternative explanation for cranial neuropathies, if there is extensive bony disease evident in the base of skull). Particular attention should also be given to ventricular size. MRIs should ideally be obtained prior to proceeding with lumbar puncture (LP), to avoid post-LP artifacts that might be confused with LM. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Diagnostic LP should be performed in the majority of patients, since neither MRI nor CSF cytology alone is sufficiently sensitive and specific. LP should be deferred in patients with large intracranial or spinal masses due to the risk of causing herniation. CSF should be routinely sent for cell count, differential, total protein, glucose and cytology. In addition, an opening pressure should be measured to screen for elevated intracranial pressure (ICP), which may be relevant for treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26458?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of leptomeningeal metastases (carcinomatous meningitis)\", section on 'Increased ICP'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3473103\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of LM should be considered in patients presenting with focal and diffuse neurological signs and symptoms. As described above, the results of MRI and analysis of CSF are complementary, and the use of both increases diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/13,38\">",
"     13,38",
"    </a>",
"    ]. A positive CSF cytology is the traditional gold standard and establishes the diagnosis of LM in 80 percent of patients (see",
"    <a class=\"local\" href=\"#H7301492\">",
"     'Cytology'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    In patients with negative cytology, a presumptive diagnosis can be made in the appropriate clinical setting, such as a patient with known metastatic cancer with typical MRI findings of diffuse linear and nodular leptomeningeal enhancement and no evidence for infection or other alternative diagnoses. In patients without a known cancer diagnosis, the diagnosis can be more difficult, and repeated LPs and sometimes open biopsy of the leptomeninges may be required to secure a diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4424?source=see_link&amp;anchor=H9#H9\">",
"     \"Approach to the patient with chronic meningitis\", section on 'Role of meningeal or brain biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various conditions can mimic the clinical presentation or MRI enhancement patterns seen in patients with LM (",
"    <a class=\"graphic graphic_table graphicRef53440 \" href=\"UTD.htm?40/4/41035\">",
"     table 2",
"    </a>",
"    ). These include metastatic disease in adjacent compartments of the nervous system (eg, base of skull, dura, or superficial brain parenchyma), infectious and autoimmune diseases affecting the leptomeninges",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nerve roots, late effects of prior treatment (eg, radiation-induced nerve root thickening",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    enhancement), and imaging artifacts such as prominent meningeal vascular enhancement or post-LP changes (although this is typically dural, not leptomeningeal, enhancement) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/48/24329/abstract/69-72\">",
"     69-72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a patient with widespread cancer, the differential diagnosis is fairly narrow, and the primary tasks are to localize the disease to the leptomeninges (as opposed to skull base or dura) and exclude infection in patients who are febrile",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunocompromised by their disease or its treatment. Patients with acute bacterial meningitis are typically quite ill, rapidly symptomatic, and febrile, and it is not difficult to distinguish them from patients with LM. Similarly, patients with aseptic meningitis usually present more acutely than patients with LM and will have one or more systemic symptoms such as fever, rash, diarrhea or malaise. If infection is suspected, CSF should be sent for routine gram stain and culture. Additional CSF tests to consider include fungal and mycobacterial cultures, AFB smear, cryptococcal antigen and virus detection assays. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=see_link&amp;anchor=H26#H26\">",
"     \"Aseptic meningitis in adults\", section on 'Approach to the patient'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    In a patient without cancer, a broader range of infectious and noninfectious meningitides must be considered (",
"    <a class=\"graphic graphic_table graphicRef76402 \" href=\"UTD.htm?28/54/29549\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4424?source=see_link\">",
"     \"Approach to the patient with chronic meningitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leptomeningeal metastases (LM) are diagnosed in approximately 5 percent of patients with advanced cancer. The most common primary tumors associated with the development of LM are breast, lung and melanoma. The incidence of LM may be increasing in cancers with improved systemic therapy options. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multifocal neurological signs and symptoms are a hallmark of the presentation of LM. Among the most common presenting symptoms are headache, nausea and vomiting, leg weakness, ataxia, altered mental status, diplopia, and facial weakness. Seizures occur in up to one quarter of patients. (See",
"      <a class=\"local\" href=\"#H7302347\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI) of the brain and spine should be performed in all patients suspected of having LM prior to lumbar puncture. Typical findings on MRI that suggest a diagnosis of LM include linear and nodular leptomeningeal enhancement, thickening and enhancement of cranial nerves or nerve roots, including the cauda equina, and hydrocephalus. (See",
"      <a class=\"local\" href=\"#H7301458\">",
"       'Neuroimaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with LM will have abnormal cerebrospinal fluid (CSF) parameters, such as mild pleocytosis, elevated total protein, decreased glucose, and elevated opening pressure. (See",
"      <a class=\"local\" href=\"#H1009947\">",
"       'Basic parameters'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The identification of malignant cells in the CSF definitively establishes the diagnosis of LM, even if the typical clinical or radiographic features are not present. However, cytology is negative in up to 20 percent of patients. CSF obtained closest to the site of symptoms (ie, intraventricularly or by cervical spine puncture under fluoroscopic guidance for cranial symptoms and LP for spinal root dysfunction) may have the highest yield. (See",
"      <a class=\"local\" href=\"#H7301492\">",
"       'Cytology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CSF flow cytometry or molecular studies may be particularly valuable in diagnosing LM from hematologic malignancies but is not routinely indicated for the evaluation of solid tumors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=see_link&amp;anchor=H7#H7\">",
"       \"Secondary involvement of the central nervous system by non-Hodgkin lymphoma\", section on 'Leptomeningeal disease'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25607?source=see_link\">",
"       \"Involvement of the central nervous system with acute myeloid leukemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Elevated tumor marker concentrations in the CSF may be helpful in selected patients, but we do not routinely do this except in cases where the clinical suspicion is high and multiple cytologic samples are negative. &nbsp;(See",
"      <a class=\"local\" href=\"#H1010278\">",
"       'Tumor markers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In exceptional cases with a negative cytology and without evidence of disseminated cancer, an open leptomeningeal biopsy may be required. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/1\">",
"      Kaplan JG, DeSouza TG, Farkash A, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 1990; 9:225.",
"     </a>",
"    </li>",
"    <li>",
"     Posner, JB. Neurologic Complications of Cancer. F.A. Davis, Philadelphia 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/3\">",
"      Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin 2003; 21:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/4\">",
"      Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982; 49:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/5\">",
"      Yap HY, Yap BS, Tashima CK, et al. Meningeal carcinomatosis in breast cancer. Cancer 1978; 42:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/6\">",
"      Chamberlain MC. Carcinomatous meningitis. Arch Neurol 1997; 54:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/7\">",
"      Jayson GC, Howell A. Carcinomatous meningitis in solid tumours. Ann Oncol 1996; 7:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/8\">",
"      Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996; 53:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/9\">",
"      Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999; 25:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/10\">",
"      DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998; 38:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/11\">",
"      Shapiro WR, Posner JB, Ushio Y, et al. Treatment of meningeal neoplasms. Cancer Treat Rep 1977; 61:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/12\">",
"      Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol 1978; 19:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/13\">",
"      Clarke JL, Perez HR, Jacks LM, et al. Leptomeningeal metastases in the MRI era. Neurology 2010; 74:1449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/14\">",
"      Lara-Medina F, Crismatt A, Villarreal-Garza C, et al. Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer. Breast J 2012; 18:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/15\">",
"      Umemura S, Tsubouchi K, Yoshioka H, et al. Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group. Lung Cancer 2012; 77:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/16\">",
"      Morris PG, Reiner AS, Szenberg OR, et al. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol 2012; 7:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/17\">",
"      Raizer JJ, Hwu WJ, Panageas KS, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 2008; 10:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/18\">",
"      Lamovec J, Zidar A. Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. An autopsy study. Arch Pathol Lab Med 1991; 115:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/19\">",
"      Lamovec J, Bracko M. Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. J Surg Oncol 1991; 48:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/20\">",
"      Altundag K, Bondy ML, Mirza NQ, et al. Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 2007; 110:2640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/21\">",
"      Saito R, Kumabe T, Jokura H, et al. Symptomatic spinal dissemination of malignant astrocytoma. J Neurooncol 2003; 61:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/22\">",
"      Hukin J, Siffert J, Cohen H, et al. Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors. Neuro Oncol 2003; 5:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/23\">",
"      Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer 2003; 97:2972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/24\">",
"      Lai R, Dang CT, Malkin MG, Abrey LE. The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 2004; 101:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/25\">",
"      Omuro AM, Kris MG, Miller VA, et al. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib. Cancer 2005; 103:2344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/26\">",
"      Emoto S, Ishigami H, Yamaguchi H, et al. Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer. Gastric Cancer 2011; 14:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/27\">",
"      Norris LK, Grossman SA, Olivi A. Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complication. J Neurooncol 1997; 32:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/28\">",
"      DeAngelis LM, Mandell LR, Thaler HT, et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989; 24:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/29\">",
"      Ahn JH, Lee SH, Kim S, et al. Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg 2012; 116:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/30\">",
"      Suki D, Abouassi H, Patel AJ, et al. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 2008; 108:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/31\">",
"      Suki D, Hatiboglu MA, Patel AJ, et al. Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. Neurosurgery 2009; 64:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/32\">",
"      Clarke JL. Leptomeningeal metastasis from systemic cancer. Continuum (Minneap Minn) 2012; 18:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/33\">",
"      Zhu JJ, Padillo O, Duff J, et al. Cavernous sinus and leptomeningeal metastases arising from a squamous cell carcinoma of the face: case report. Neurosurgery 2004; 54:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/34\">",
"      Lossos A, Siegal T. Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance. Neurology 1992; 42:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/35\">",
"      Hansen K, Gjerris F, S&oslash;rensen PS. Absence of hydrocephalus in spite of impaired cerebrospinal fluid absorption and severe intracranial hypertension. Acta Neurochir (Wien) 1987; 86:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/36\">",
"      Laas R, Arnold H. Compression of the outlets of the leptomeningeal veins--the cause of intracranial plateau waves. Acta Neurochir (Wien) 1981; 58:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/37\">",
"      Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Arch Neurol 1989; 46:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/38\">",
"      Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999; 246:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/39\">",
"      Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 1995; 38:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/40\">",
"      Chamberlain MC, Sandy AD, Press GA. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 1990; 40:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/41\">",
"      Chamberlain MC. Comparative spine imaging in leptomeningeal metastases. J Neurooncol 1995; 23:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/42\">",
"      Singh SK, Leeds NE, Ginsberg LE. MR imaging of leptomeningeal metastases: comparison of three sequences. AJNR Am J Neuroradiol 2002; 23:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/43\">",
"      Kleinschmidt-DeMasters BK, Damek DM. The imaging and neuropathological effects of Bevacizumab (Avastin) in patients with leptomeningeal carcinomatosis. J Neurooncol 2010; 96:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/44\">",
"      Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998; 82:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/45\">",
"      Chamberlain MC, Kormanik PA, Glantz MJ. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro Oncol 2001; 3:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/46\">",
"      Hauke RJ, Tarantolo SR, Bashir RM, et al. Central nervous system Hodgkin's disease relapsing with eosinophilic pleocytosis. Leuk Lymphoma 1996; 21:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/47\">",
"      Lossos A, Siegal T. Spinal subarachnoid hemorrhage associated with leptomeningeal metastases. J Neurooncol 1992; 12:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/48\">",
"      Chamberlain MC. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology 1998; 50:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/49\">",
"      Bigner SH. Cerebrospinal fluid (CSF) cytology: current status and diagnostic applications. J Neuropathol Exp Neurol 1992; 51:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/50\">",
"      Hoon DS, Kuo CT, Wascher RA, et al. Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients. J Invest Dermatol 2001; 117:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/51\">",
"      Malkin MG, Posner JB. Cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastases. Eur J Cancer Clin Oncol 1987; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/52\">",
"      Stockhammer G, Poewe W, Burgstaller S, et al. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology 2000; 54:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/53\">",
"      van Zanten AP, Twijnstra A, Ongerboer de Visser BW, et al. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy. J Neurol Neurosurg Psychiatry 1991; 54:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/54\">",
"      Castro MP, McDonald TJ, Qualman SJ, Odorisio TM. Cerebrospinal fluid gastrin releasing peptide in the diagnosis of leptomeningeal metastases from small cell carcinoma. Cancer 2001; 91:2122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/55\">",
"      Fujimaki T, Mishima K, Asai A, et al. Levels of beta-human chorionic gonadotropin in cerebrospinal fluid of patients with malignant germ cell tumor can be used to detect early recurrence and monitor the response to treatment. Jpn J Clin Oncol 2000; 30:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/56\">",
"      Jorda M, Ganjei-Azar P, Nadji M. Cytologic characteristics of meningeal carcinomatosis: increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry. Arch Neurol 1998; 55:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/57\">",
"      Bernstein WB, Kemp JD, Kim GS, Johnson VV. Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer. J Clin Oncol 2008; 26:3281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/58\">",
"      Cone LA, Koochek K, Henager HA, et al. Leptomeningeal carcinomatosis in a patient with metastatic prostate cancer: case report and literature review. Surg Neurol 2006; 65:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/59\">",
"      Kosmas C, Tsavaris NB, Soukouli G, et al. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer. Med Oncol 2005; 22:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/60\">",
"      Walbert T, Groves MD. Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment. Future Oncol 2010; 6:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/61\">",
"      van de Langerijt B, Gijtenbeek JM, de Reus HP, et al. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases. Neurology 2006; 67:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/62\">",
"      Reijneveld JC, Brandsma D, Boogerd W, et al. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases. Neurology 2005; 65:1120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/63\">",
"      Friedberg MH, Glantz MJ, Klempner MS, et al. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 1998; 82:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/64\">",
"      Katopodis N, Glantz MJ, Kim L, et al. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies. Cancer 2001; 92:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/65\">",
"      Groves MD, Hess KR, Puduvalli VK, et al. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. J Neurooncol 2009; 94:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/66\">",
"      Le Rhun E, Massin F, Tu Q, et al. Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis. BMC Clin Pathol 2012; 12:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/67\">",
"      Le Rhun E, Tu Q, De Carvalho Bittencourt M, et al. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis. Med Oncol 2013; 30:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/68\">",
"      Patel AS, Allen JE, Dicker DT, et al. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2011; 2:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/69\">",
"      Mokri B. Spontaneous intracranial hypotension. Curr Neurol Neurosci Rep 2001; 1:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/70\">",
"      Olsan AD, Milburn JM, Baumgarten KL, Durham HL. Leptomeningeal enhancement in a patient with proven West Nile virus infection. AJR Am J Roentgenol 2003; 181:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/71\">",
"      Hsia AW, Katz JS, Hancock SL, Peterson K. Post-irradiation polyradiculopathy mimics leptomeningeal tumor on MRI. Neurology 2003; 60:1694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/48/24329/abstract/72\">",
"      Ducray F, Guillevin R, Psimaras D, et al. Postradiation lumbosacral radiculopathy with spinal root cavernomas mimicking carcinomatous meningitis. Neuro Oncol 2008; 10:1035.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5185 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.66.252.144-2A34E2F131-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24329=[""].join("\n");
var outline_f23_48_24329=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7302347\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008145\">",
"      - Headache",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008198\">",
"      - Altered mental status",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008206\">",
"      - Cranial neuropathies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008420\">",
"      - Cerebellar dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008428\">",
"      - Radiculopathy and cauda equina syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008445\">",
"      - Seizures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H263250910\">",
"      - Plateau waves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1008478\">",
"      - Other symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7301458\">",
"      Neuroimaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1009751\">",
"      - Brain MRI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1009758\">",
"      - Spine MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7301485\">",
"      Cerebrospinal fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1009947\">",
"      - Basic parameters",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7301492\">",
"      - Cytology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7301581\">",
"      - Flow cytometry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1010278\">",
"      - Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H363877\">",
"      - Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3473096\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3473103\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/5185\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5185|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/26/37286\" title=\"diagnostic image 1\">",
"      Brain MRI findings in leptomeningeal metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/39/18036\" title=\"diagnostic image 2\">",
"      Sagittal brain MRI in leptomeningeal metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/5/17494\" title=\"diagnostic image 3\">",
"      Hydrocephalus in leptomeningeal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/13/40146\" title=\"diagnostic image 4\">",
"      Spine MRI findings in leptomeningeal metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5185|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/23/33144\" title=\"figure 1\">",
"      Tumor spread into leptomeningeal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/8/21634\" title=\"figure 2\">",
"      Cervical dermatomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/36/10822\" title=\"figure 3\">",
"      Lumbosacral dermatomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5185|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/51/28471\" title=\"picture 1\">",
"      Leptomeningeal melanoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/26/25007\" title=\"picture 2\">",
"      CSF cytology in a patient with adenocarcinoma of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/5185|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/56/36747\" title=\"table 1\">",
"      Cerebrospinal fluid biochemical markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/4/41035\" title=\"table 2\">",
"      Differential diagnosis of leptomeningeal metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/54/29549\" title=\"table 3\">",
"      Etiology of chronic meningitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/44/5832?source=related_link\">",
"      Anatomy and localization of spinal cord disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4424?source=related_link\">",
"      Approach to the patient with chronic meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/3/15417?source=related_link\">",
"      Aseptic meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33402?source=related_link\">",
"      Evaluation and management of elevated intracranial pressure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/0/25607?source=related_link\">",
"      Involvement of the central nervous system with acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/46/25320?source=related_link\">",
"      Overview of diplopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14570?source=related_link\">",
"      Polyradiculopathy: spinal stenosis, infectious, carcinomatous, and inflammatory nerve root syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/17/39194?source=related_link\">",
"      Secondary involvement of the central nervous system by non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26458?source=related_link\">",
"      Treatment of leptomeningeal metastases (carcinomatous meningitis)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_48_24330="Coronary artery distribution for D-TGA";
var content_f23_48_24330=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54020&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Coronary artery distribution for D-transposition of the great arteries",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 788px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronary artery distribution in TGA.",
"    <br>",
"     (Upper panels) Diagnostic projection; diagram of the origin and proximal course as visualized by two-dimensional echocardiography and caudally angulated aortography (see text).",
"     <br>",
"      (Lower panels) Same coronary artery distribution as viewed anteriorly (surgeon's view, frontal projection). Note that the circumflex coronary artery, or even the entire left coronary artery system, is more likely to pursue a retropulmonary course (dashed lines) when the great arteries are in a side-by-side relationship (shown). An intramural course (shaded) of the proximal coronary artery exists in &lt;3 percent of cases but has been associated with higher risk for transfer during an arterial switch operation. Alternative terminology in brackets is shown as popularized by Quagebeur and Kirklin and the Congenital Heart Surgeons Society.",
"      <div class=\"footnotes\">",
"       Ant: anterior; Cx: circumflex coronary artery; Inf: inferior; L: left; LAD: left anterior descending coronary artery; Post: posterior; R: right; RCA: right coronary artery; Sup: superior.",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Wernovsky G, Sanders SP. Coronary artery anatomy and transposition of the great arteries. Coron Artery Dis 1993; 4:148. Copyright &copy; 1993 Lippincott Williams &amp; Wilkins.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24330=[""].join("\n");
var outline_f23_48_24330=null;
var title_f23_48_24331="Labs organ donor";
var content_f23_48_24331=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory testing for the pediatric potential organ donor",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Basic lab tests - CBC, Biochemical screen, AST, ALT, GGT, PT, PTT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ABO blood group typing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Blood for HLA typing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        In certain cases inguinal lymph nodes may be taken to facilitate tissue typing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Microbiological studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Microscopy, culture and sensitivity of blood, urine and sputum samples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Viral serology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Epstein-Barr virus (EBV), cytomegalovirus (CMV), Human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg), hepatitis B core antibody (HBcAb), hepatitis C virus (HCV)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syphilis screening: VDRL or RPR",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Additional laboratory tests may be requested by the Organ Procurement Organization",
"    <div class=\"footnotes\">",
"     <p>",
"      CBC: complete blood count; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma glutamyl transpeptidase; PT: prothrombin time; PTT: partial thromboplastin time; HLA: human leukocyte antigens; VDRL: venereal disease research laboratory; RPR: rapid plasma reagin.",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24331=[""].join("\n");
var outline_f23_48_24331=null;
var title_f23_48_24332="Modified Bell staging NEC";
var content_f23_48_24332=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F54166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F54166&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Modified Bell staging criteria for necrotizing enterocolitis (NEC) in neonates",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"5%\">",
"     </colgroup>",
"     <colgroup span=\"4\" width=\"23%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Classification of NEC",
"       </td>",
"       <td class=\"subtitle1\">",
"        Systemic signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Abdominal signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Radiographic signs",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        IA",
"       </td>",
"       <td>",
"        Suspected",
"       </td>",
"       <td>",
"        Temperature instability, apnea, bradycardia, lethargy",
"       </td>",
"       <td>",
"        Gastric retention, abdominal distention, emesis, heme-positive stool",
"       </td>",
"       <td>",
"        Normal or intestinal dilation, mild ileus",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        IB",
"       </td>",
"       <td>",
"        Suspected",
"       </td>",
"       <td>",
"        Same as above",
"       </td>",
"       <td>",
"        Grossly bloody stool",
"       </td>",
"       <td>",
"        Same as above",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        IIA",
"       </td>",
"       <td>",
"        Definite, mildly ill",
"       </td>",
"       <td>",
"        Same as above",
"       </td>",
"       <td>",
"        Same as above, plus absent bowel sounds with or without abdominal tenderness",
"       </td>",
"       <td>",
"        Intestinal dilation, ileus, pneumatosis intestinalis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        IIB",
"       </td>",
"       <td>",
"        Definite, moderately ill",
"       </td>",
"       <td>",
"        Same as above, plus mild metabolic acidosis and thrombocytopenia",
"       </td>",
"       <td>",
"        Same as above, plus absent bowel sounds, definite tenderness, with or without abdominal cellulitis or right lower quadrant mass",
"       </td>",
"       <td>",
"        Same as IIA, plus ascites",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        IIIA",
"       </td>",
"       <td>",
"        Advanced, severely ill, intact bowel",
"       </td>",
"       <td>",
"        Same as IIB, plus hypotension, bradycardia, severe apnea, combined respiratory and metabolic acidosis, DIC, and neutropenia",
"       </td>",
"       <td>",
"        Same as above, plus signs of peritonitis, marked tenderness, and abdominal distention",
"       </td>",
"       <td>",
"        Same as IIA, plus ascites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IIIB",
"       </td>",
"       <td>",
"        Advanced, severely ill, perforated bowel",
"       </td>",
"       <td>",
"        Same as IIIA",
"       </td>",
"       <td>",
"        Same as IIIA",
"       </td>",
"       <td>",
"        Same as above, plus pneumoperitoneum",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     DIC: disseminated intravascular coagulation.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Neu J. Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996; 43:409.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24332=[""].join("\n");
var outline_f23_48_24332=null;
var title_f23_48_24333="AHT drugs and proteinuria in DM";
var content_f23_48_24333=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F57267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F57267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Antihypertensive drugs and urinary protein excretion in diabetic nephropathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 419px; height: 207px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Protein excretion at baseline (black columns) and after one year of antihypertensive therapy (hatched columns) in patients with type 2 diabetes treated with lisinopril (mean dose 29 mg/day), verapamil (mean dose 360 mg/day), half-dose lisinopril plus verapamil, or hydrochlorothiazide plus guanfacine (which has a mechanism of action similar to methyldopa). The last regimen had little or no antiproteinuric effect while the fall in protein excretion with the lisinopril-verapamil combination (75 percent) was additive to the action of either drug alone (roughly 50 percent).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bakris GL, Barnhill BW, Sadler R. Kidney Int 1992; 41:912.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24333=[""].join("\n");
var outline_f23_48_24333=null;
var title_f23_48_24334="VIP germ cell tumors";
var content_f23_48_24334=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F51451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F51451&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cisplatin, etoposide, and ifosfamide for relapsed germ cell tumors (VIP)",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        <p>",
"         Cycle length: 21 days.",
"        </p>",
"        Total cycles: 4.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cisplatin",
"        </strong>",
"       </td>",
"       <td>",
"        20 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV per day",
"       </td>",
"       <td>",
"        Dilute with 250 mL normal saline (NS) and administer over one hour. Do not administer with aluminum needles or intravenous sets.",
"       </td>",
"       <td>",
"        Days 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Etoposide",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        75 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV per day",
"       </td>",
"       <td>",
"        Dilute with 500 mL NS (concentration less than 0.4 mg/mL) and administer over one hour.",
"       </td>",
"       <td>",
"        Days 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Ifosfamide",
"        </strong>",
"        *",
"       </td>",
"       <td>",
"        1200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day continuous IV infusion",
"       </td>",
"       <td>",
"        Dilute with NS for injection to a final concentration of 0.6 to 20 mg/mL and infuse over 24 hours. Can mix with Mesna.",
"       </td>",
"       <td>",
"        Days 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mesna",
"        </strong>",
"       </td>",
"       <td>",
"        120 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute with NS for injection and administer via slow IV push prior to day 1 infusion of ifosfamide. Total concentration of mesna should not exceed 20 mg/mL.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Mesna",
"        </strong>",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per day continuous IV infusion",
"       </td>",
"       <td>",
"        Dilute with NS for injection and administer as continuous infusion over 24 hours",
"        <sup>",
"         [2]",
"        </sup>",
"        . Total concentration of mesna should not exceed 20 mg/mL. Can mix with ifosfamide.",
"       </td>",
"       <td>",
"        Days 1 to 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Induction of diuresis using intravenous NS minimizes the risk of cisplatin nephrotoxicity. At least 2000 mL of NS should be administered at a rate of 100 to 125 mL per hour throughout the five days of treatment and continued for at least two hours after the last dose of cisplatin. Refer to UpToDate topic on \"Cisplatin nephrotoxicity\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent frequency of emesis). Aprepitant can be given orally (125 mg on day 1, 80 mg on days 2 and 3) with ondansetron, prochlorperazine, and dexamethasone daily. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Cisplatin is an irritant but can cause significant tissue damage; avoid extravasation",
"        <sup>",
"         [3]",
"        </sup>",
"        . Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with granulocyte colony stimulating factors was administered as a routine component of this regimen",
"        <sup>",
"         [1]",
"        </sup>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Dose adjustment in the setting of baseline renal impairment (ie, creatinine &gt;3.0 mg/dL or GFR &lt;50 mL/min) requires a balanced discussion of the goals of treatment and the risks of cisplatin. Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Basic metabolic panel (creatinine and electrolytes) prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Liver function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Cisplatin is associated with significant nephrotoxicity. Ifosfamide is associated with cumulative nephrotoxicity, mostly at a total dose above 60 grams/m",
"        <sup>",
"         2",
"        </sup>",
"        . Clinical manifestations may include hypophosphatemia, renal potassium wasting, metabolic acidosis with a normal ion gap, and rarely, polyuria due to nephrogenic diabetes insipidus. Assess creatinine and electrolytes, including potassium and phosphate, daily during treatment and prior to each subsequent treatment cycle. Refer to UpToDate topic on \"Ifosfamide nephrotoxicity\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Mesna does not prevent hemorrhagic cystitis in all patients",
"        <sup>",
"         [2]",
"        </sup>",
"        . Monitor a morning specimen of urine for hematuria daily, on days 1 through 5. Refer to UpToDate topic on \"Cystitis in patients with cancer\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for neurotoxicity (confusion, coma, rarely seizures, weakness, neuropathy, ataxia, cranial nerve dysfunction) daily, on days 1 through 5. Central nervous system side effects may be especially problematic for those over age 60. Refer to UpToDate topic on \"Neurologic complications of non-platinum cancer chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor vital signs during etoposide infusion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for hearing loss prior to each dose of cisplatin; audiometry as clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        Reduce doses of etoposide and ifosfamide each by 25 percent for subsequent cycles for granulocytopenic fever or thrombocytopenic bleeding with the previous course of therapy",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurotoxicity:",
"        </strong>",
"        Neuropathy usually is seen after cumulative doses of cisplatin beyond 400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        , although there is marked interindividual variation. Patients with mild neuropathy can continue to receive full cisplatin doses. However, if the neuropathy interferes with function, the risk of potentially disabling neurotoxicity must be weighed against the benefit of continued treatment",
"        <sup>",
"         [3]",
"        </sup>",
"        . Refer to UpToDate topic on \"Neurologic complications of platinum-based chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Nephrotoxicity:",
"        </strong>",
"        It is recommended that subsequent doses of cisplatin be withheld until the serum creatinine is less than 3.0 mg/dL.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; GFR: glomerular filtration rate; CBC: complete blood count.",
"     <br/>",
"     * The initial protocol included empiric reduction of etoposide and ifosfamide doses by 25 percent for patients who have received prior radiation therapy",
"     <sup>",
"      [1]",
"     </sup>",
"     .",
"     <br/>",
"     &Delta; Due to a longer half-life of ifosfamide and associated metabolites at higher doses, some references recommend continuation of mesna for 12 to 24 hours beyond completion of ifosfamide to reduce the risk of hemorrhagic cystitis",
"     <sup>",
"      [2]",
"     </sup>",
"     .",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Nichols CR, et al. J Clin Oncol 1998; 16:1287.",
"      </li>",
"      <li>",
"       MESNA injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed December 20, 2011).",
"      </li>",
"      <li>",
"       Platinol (cisplatin) injection, powder, lyophilized, for solution. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 20, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24334=[""].join("\n");
var outline_f23_48_24334=null;
var title_f23_48_24335="Human parathyroid hormone";
var content_f23_48_24335=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F54710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F54710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 543px\">",
"   <div class=\"ttl\">",
"    Parathyroid hormone (PTH)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 523px; height: 387px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Parathyroid hormone (PTH) is an 84-amino acid polypeptide secreted by the parathyroid glands. It has an N-terminal (H2N) and a C-terminal region (COOH). PTH 1-34 is shown in yellow; PTH 1-84 is the full-length polypeptide.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_48_24335=[""].join("\n");
var outline_f23_48_24335=null;
